<html xmlns="http://www.w3.org/1999/xhtml"> <head> <style type="text/css">
      	     		 
      	    a                          {background : #ffffff; }
      	    article                    {border-style : dotted; border-width : 2px; }
		 	
		 	div                        {background : #ffffcc;}
		 	div.abstract-title         {font-weight : bold ; font-size : 16pt;}
		 	div.ack                    {border-style : solid ; border-color : red; margin : 2em; }
		 	div.article-meta           {border-style : solid; border-width : 1 pt; margin 1em;}
		 	div.boxed-text             {margin : 5em; border-style : solid;}
		 	div.contrib-group          {margin : 1em; }
		 	div.fig                    {border-style : solid; border-width : 2px; margin : 2em; }
		 	div.funding                {font-weight : bold ; font-size : 16pt;}
		 	div.given-names            {font-style : italic;}
		 	div.intro                  {border-style : inset; margin : 5px;}
		 	div.introduction           {border-style : inset; margin : 5px;}
		 	div.journal-meta           {border-style : solid; border-width : 1 pt; margin 1em;}
		 	div.journal-title-group    {background : #ffeeee;}
		 	div.article-title          {font-weight : bold ; font-size : 18pt;}
		 	div.kwd                    {font-style : italic}
		 	div.meta-name              {font-weight : bold ; font-size : 16pt;}
		 	div.name                   {font-weight : bold;}
		 	div.alt-title              {font-style : italic; font-size : 12px;}
		 	
		 	div.sec                    {border : 2px; margin 5px; padding 2px;}
		 	div.title                  {font-family : courier; font-weight : bold;
		 	                            font-size : 16pt; margin : 5px;}
		 	
		 	div.materials_methods      {border-style : double; margin : 5px; }
		 	div.methods                {border-style : double; margin : 5px; }
		 	
		 	div.results                {border-style : solid; margin : 5px;}
		 	div.background             {border-style : dotted; margin : 5px;}
		 	
		 	div.discussion             {border-style : groove; margin : 5px;}
		 	div.conclusion             {border-style : ridge; margin : 5px;}
		 	div.conclusions             {border-style : ridge; margin : 5px;}
		 	div.supplementary-material {border-style : inset; margin : 5px;}
		 	div.abbreviations          {border-style : double; border-color : red; margin : 5px;}
		 	div.competinginterests     {border-style : double; border-color : blue; margin : 5px;}
		 	div.acknowledgements       {border-style : double; border-color : green; margin : 5px;}
		 	div.authors_contributions   {border-style : double; border-color : purple; margin : 5px;}
		 	
		 	div.publisher              {border-style : outset; margin : 5px;}
		 	div.fn-type-conflict       {background : #f88; }
		 	div.fn-type-con            {background : #ddf; }
		 	div.fn-type-other          {background : #ddd; }
		 	
		 	div.unknown                {background : #ffd;
									 	  border-style : solid;
									 	  border-width : 1px;
									 	  padding : 2 px;}
		 	  
      	    table                      {background : #ffffdd;}
		 	tr                         {background : #ddddff; padding : 1px;}
		 	
		 	span                       {background : #ffcccc;}
		 	
		 	span.citation-author       {font-family : helvetica; background : #ffeeee;}
		 	span.collab                {background : #ddffff; }
		 	span.comment               {font-family : courier; font-size : 6px; background : #ffaaff;}
		 	span.contrib               {background : #ffffff;}
		 	span.corresp               {background : #ddffdd; }
		 	span.doi                   {background : #ffffff;}
		 	span.email                 {font-family : courier; }
		 	span.etal                  {font-style : italic;}
		 	span.fpage                 {font-family : courier;}
		 	span.given-names           {background : #ffffff;}
		 	span.iso-abbrev            {background : #ffffff;}
		 	span.issn-epub             {background : #ffffff;}
		 	span.issn-ppub             {background : #ffffff;}
		 	span.journal-title         {background : #ffffff;}
		 	span.lpage                 {font-family : courier;}
		 	span.mixed-article-title   {font-style : italic ;}
		 	span.nlm-ta                {background : #ffffff;}
		 	span.pmc                   {background : #ffffff;}
		 	span.pmcid                 {background : #ffffff;}
		 	span.pmid                  {background : #ffffff;}
		 	span.publisher             {background : #ffffff;}
		 	span.publisher-id          {background : #ffffff;}
		 	span.publisher-name        {background : #ffffff;}
		 	span.source                {background : #ffffff;}
		 	span.subject               {background : #ffffff;}
		 	span.surname               {background : #ffffff;}
		 	span.volume                {font-family : courier; font-weight : bold;}
		 	span.year                  {font-family : courier ; font-style : italic;}
			</style> </head> <body> <div class="front" title="front"> <div class="journal-meta" tagx="journal-meta" title="journal-meta"><span class="nlm-ta" title="nlm-ta">Life Sci</span><span class="iso-abbrev" title="iso-abbrev">Life Sci</span><div class="journal-title-group" tagx="journal-title-group" title="journal-title-group"><span class="journal-title" tagx="journal-title" title="journal-title">Life Sciences</span></div><span class="issn-ppub" tagx="issn" title="issn-ppub">0024-3205</span><span class="issn-epub" tagx="issn" title="issn-epub">1879-0631</span><div class="publisher" tagx="publisher" title="publisher"><span class="publisher-name" tagx="publisher-name" title="publisher-name">Elsevier Inc.</span></div> </div> <div class="article-meta" tagx="article-meta" title="article-meta"><span class="publisher-id" title="publisher-id">S0024-3205(20)30581-6</span><span class="doi" title="doi"> doi: <a href="https://dx.doi.org/10.1016/j.lfs.2020.117831">10.1016/j.lfs.2020.117831</a></span><span class="publisher-id" title="publisher-id">117831</span><div class="article-categories" title="article-categories">
: <span class="subject" title="subject">Article</span></div> <div class="title-group" tagx="title-group" title="title-group"> <div class="article-title" title="article-title">
Unravelling lead antiviral phytochemicals for the inhibition of SARS-CoV-2 M<sup>pro</sup> enzyme through in silico approach</div> </div> <div class="contrib-group" title="contrib-group"><span class="contrib" title="contrib"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Gurung</span><span class="given-names" tagx="given-names" title="given-names">Arun Bahadur</span></span><span class="email" tagx="email" title="email">arunbgurung@gmail.com</span><a href="#af0005">a</a><a href="#cr0005">â�Ž</a></span><span class="contrib" title="contrib"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Ali</span><span class="given-names" tagx="given-names" title="given-names">Mohammad Ajmal</span></span><a href="#af0010">b</a></span><span class="contrib" title="contrib"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Lee</span><span class="given-names" tagx="given-names" title="given-names">Joongku</span></span><a href="#af0015">c</a></span><span class="contrib" title="contrib"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Farah</span><span class="given-names" tagx="given-names" title="given-names">Mohammad Abul</span></span><a href="#af0020">d</a></span><span class="contrib" title="contrib"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Al-Anazi</span><span class="given-names" tagx="given-names" title="given-names">Khalid Mashay</span></span><a href="#af0020">d</a></span><span class="citation_author_institution" id="af0005">[a], </span><span class="citation_author_institution" id="af0010">[b], </span><span class="citation_author_institution" id="af0015">[c], </span><span class="citation_author_institution" id="af0020">[d], </span></div> <div class="author-notes" title="author-notes"> <div class="corresp" title="corresp"><span class="label" tagx="label" title="label">â�Ž</span>Corresponding author. <span class="email" tagx="email" title="email">arunbgurung@gmail.com</span></div> </div><span class="pub-date-pmc-release" title="pub-date-pmc-release">pmc-release: <span>2020-5-5</span></span><span class="pub-date-ppub" title="pub-date-ppub">ppub: <span>2020-8-8</span></span><span class="pub-date-epub" title="pub-date-epub">epub: <span>2020-5-5</span></span><span class="volume" tagx="volume" title="volume">255</span><span class="fpage" tagx="fpage" title="fpage">117831</span><span class="lpage" tagx="lpage" title="lpage">117831</span><span class="history" title="history"><span class="received" title="received">received: 2020-3-28</span><span class="rev-recd" title="rev-recd">rev-recd: 2020-5-11</span><span class="accepted" title="accepted">accepted: 2020-5-19</span></span><div class="permissions"><span class="copyright" title="copyright">(C) <span class="copyright-holder" tagx="copyright-holder" title="copyright-holder">Elsevier Inc.</span>, <span class="copyright-year" tagx="copyright-year" title="copyright-year">2020</span></span><span class="license" title="license"><span class="license-p" title="license-p">Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.</span></span></div> <div class="abstract" title="abstract"> <div class="abstract-title" title="abstract-title">
Abstract</div> <p>A new SARS coronavirus (SARS-CoV-2) belonging to the genus <i>Betacoronavirus</i> has caused a pandemic known as COVID-19. Among coronaviruses, the main protease (M<sup>pro</sup>) is an essential drug target which, along with papain-like proteases catalyzes the processing of polyproteins translated from viral RNA and recognizes specific cleavage sites. There are no human proteases with similar cleavage specificity and therefore, inhibitors are highly likely to be nontoxic. Therefore, targeting the SARS-CoV-2 M<sup>pro</sup> enzyme with small molecules can block viral replication. The present study is aimed at the identification of promising lead molecules for SARS-CoV-2 M<sup>pro</sup> enzyme through virtual screening of antiviral compounds from plants. The binding affinity of selected small drug-like molecules to SARS-CoV-2 M<sup>pro</sup>, SARS-CoV M<sup>pro</sup> and MERS-CoV M<sup>pro</sup> were studied using molecular docking. Bonducellpin D was identified as the best lead molecule which shows higher binding affinity (âˆ’9.28Â kcal/mol) as compared to the control (âˆ’8.24Â kcal/mol). The molecular binding was stabilized through four hydrogen bonds with Glu166 and Thr190 as well as hydrophobic interactions via eight residues. The SARS-CoV-2 M<sup>pro</sup> shows identities of 96.08% and 50.65% to that of SARS-CoV M<sup>pro</sup> and MERS-CoV M<sup>pro</sup> respectively at the sequence level. At the structural level, the root mean square deviation (RMSD) between SARS-CoV-2 M<sup>pro</sup> and SARS-CoV M<sup>pro</sup> was found to be 0.517Â Ã… and 0.817Â Ã… between SARS-CoV-2 M<sup>pro</sup> and MERS-CoV M<sup>pro</sup>. Bonducellpin D exhibited broad-spectrum inhibition potential against SARS-CoV M<sup>pro</sup> and MERS-CoV M<sup>pro</sup> and therefore is a promising drug candidate, which needs further validations through in vitro and in vivo studies.</p> </div> <div class="kwd-group"> <div class="title" tagx="title" title="title">
Abbreviations</div> <div class="kwd" title="kwd">
ACE-2, Angiotensin Converting Enzyme 2</div> <div class="kwd" title="kwd">
BLAST, Basic Local Alignment Search</div> <div class="kwd" title="kwd">
cLogP, partition coefficient between N-octanol and water</div> <div class="kwd" title="kwd">
HBA, hydrogen bond acceptor</div> <div class="kwd" title="kwd">
HBD, hydrogen bond donor</div> <div class="kwd" title="kwd">
MERS-CoV, Middle East respiratory syndrome coronavirus</div> <div class="kwd" title="kwd">
Mpro, main protease</div> <div class="kwd" title="kwd">
MW, molecular weight</div> <div class="kwd" title="kwd">
PDB, Protein Data Bank</div> <div class="kwd" title="kwd">
RMSD, root mean square deviation</div> <div class="kwd" title="kwd">
ROF, rule of five</div> <div class="kwd" title="kwd">
SARS-CoV, severe acute respiratory syndrome coronavirus</div> </div> <div class="kwd-group"> <div class="title" tagx="title" title="title">
Keywords</div> <div class="kwd" title="kwd">
Molecular docking</div> <div class="kwd" title="kwd">
Antiviral properties</div> <div class="kwd" title="kwd">
Phytochemicals</div> <div class="kwd" title="kwd">
Medicinal plants</div> <div class="kwd" title="kwd">
SARS-CoV-2</div> <div class="kwd" title="kwd">
COVID-19</div> <div class="kwd" title="kwd">
Binding affinity</div> <div class="kwd" title="kwd">
SARS-CoV-2 M<sup>pro</sup></div> </div> </div> </div> <div class="body" title="body"> <div class="introduction" title="sec"><span class="label" tagx="label" title="label">1</span><div class="title" tagx="title" title="title">
Introduction</div> <p id="p0005">Coronaviruses (CoVs) are positive-sense RNA enveloped viruses which derive their name from the crown-like spikes on their surface and they belong to Coronaviridae family. They are classified into four main subgroups- alpha, beta, gamma, and delta depending on their genomic structure [<a href="#bb0005">1</a>]. Alpha- and beta coronaviruses cause respiratory infections in humans and gastroenteritis in other mammals [<a href="#bb0010">2</a>,<a href="#bb0015">3</a>]. Until the last year, only six different coronaviruses causing infection in humans were known. Four of this (HCoV-NL63, HCoV-229E, HCoV-OC43 and HKU1) cause mild common cold-type symptoms in healthy individuals and the other two which caused epidemics in the last two decades. The severe acute respiratory syndrome coronavirus (SARS-CoV) caused a SARS epidemic in 2002â€"2003 with a 10% mortality rate. Likewise, the Middle East respiratory syndrome coronavirus (MERS-CoV) caused a disastrous pandemic in 2012 leading to 37% mortality [<a href="#bb0005">1</a>]. All coronaviruses infecting humans usually known to have intermediate hosts such as bats or rodents [<a href="#bb0020">4</a>]. Previous outbreaks of SARS-CoV and MERS-CoV involved civet cats and dromedary camels for their direct transmission to humans [<a href="#bb0005">1</a>]. A new coronavirus caused an outbreak of the pulmonary disease in Wuhan (the capital of Hubei province in China) in December 2019 and has since spread across different parts of the world [<a href="#bb0025">5</a>,<a href="#bb0030">6</a>]. Since its RNA genome shows about 82% identity to that of the SARS coronavirus (SARS-CoV), the new virus has been termed as SARS-CoV-2 [<a href="#bb0035">7</a>]. However, both these viruses belong to the same clade of the genus <i>Betacoronavirus</i> [<a href="#bb0025">5</a>,<a href="#bb0030">6</a>]. The SARS-CoV-2 caused a disease known as COVID-19. At the initial outbreak, cases were linked to the Huanan seafood and animal market in Wuhan but active human-to-human transmission caused exponential growth in the number of reported cases. The World Health Organization (WHO) confirmed the outbreak a pandemic on March 11, 2020. There have been &amp;gt;170,000 cumulative cases worldwide accounting for approximately 3.7% case-fatality rate as of March 15, 2020 [<a href="#bb0040">8</a>].</p> <p id="p0010">Due to the close similarity to SARS-CoV, the biochemical interactions and the pathogenesis of SARS-CoV-2 are highly likely to be similar [<a href="#bb0005">1</a>]. The virus entry into the host cell is mainly mediated through the binding of the SARS spike (S) protein to the angiotensin-converting enzyme 2 (ACE-2) receptor on the cell surface [<a href="#bb0045">9</a>]. Among coronaviruses, the main protease (M<sup>pro</sup>, also called 3CL<sup>pro</sup>) has emerged as the best-described drug target [<a href="#bb0050">10</a>]. The polyproteins that are translated from the viral RNA are processed by this enzyme together with the papain-like protease(s) [<a href="#bb0055">11</a>]. The M<sup>pro</sup> recognizes and acts remarkably on eleven cleavage sites typically Leu-Glnâ†"(Ser,Ala,Gly) on the large polyprotein 1ab (replicase 1ab) of approximately 790Â kDa. Blocking the activity of this enzyme would help in inhibiting viral replication. There are no reported human proteases with a similar cleavage specificity and therefore, inhibitors against this enzyme are less probable to be toxic [<a href="#bb0040">8</a>]. The three dimensional X-ray crystal structure of this enzyme in complex with Î±-ketoamide inhibitor 13b (O6K) was recently solved by Zhang et al. [<a href="#bb0040">8</a>] (PDB ID: <a href="pdb:6Y2F">6Y2F</a>) which offers an opportunity for structure-based drug design against the enzyme target. Understanding the relevance of the steady rise in the number of infected and death cases in recent time from COVID-19 and lack of effective therapeutic interventions such as drugs and vaccines, computer-aided drug design is an important strategy to be sought after. This rational based drug design will reduce the cost and time incurred in the drug discovery process. Structure-based drug design primarily relies on molecular docking to identify lead molecules against the target proteins from chemical libraries [<a href="#bb0060">12</a>,<a href="#bb0065">13</a>]. Compared to the synthetic inhibitors plant based-drugs have less toxicity and much safer to use. The natural products such as traditional medicines and plant-derived compounds (phytochemicals) are the rich sources of promising antiviral drugs [<a href="#bb0070">14</a>]. Around 44% of the approved antiviral drugs between 1981 and 2006 were derived from natural products [<a href="#bb0075">15</a>]. The plant extracts have been extensively used and screened for drug molecules to evaluate theirs in vitro antiviral activities. Few examples of medicinal plants with proven antiviral activities include <i>Phyllanthus amarus</i> Schum. and Thonn which blocks human immunodeficiency virus (HIV) replication both in vitro and in vivo [<a href="#bb0080">16</a>]; <i>Azadirachta indica</i> Juss. (Neem) shows in vitro and in vivo inhibition properties against Dengue virus type-2 (DENV-2) [<a href="#bb0085">17</a>]; <i>Geranium sanguineum</i> L. significantly inhibits the replication of Herpes simplex virus type-1 and 2 (HSV-1 and HSV-2) in vitro [<a href="#bb0090">18</a>]; <i>Acacia nilotica</i> L. possesses activity against Hepatitis C virus (HCV) in vitro etc. [<a href="#bb0095">19</a>].</p> <p id="p0015">In the present study, we have screened small drug-like molecules from a dataset of phytochemicals possessing antiviral activities using drug-like filters and toxicity studies. The selected molecules were evaluated for their binding affinity to SARS-CoV-2 M<sup>pro</sup> enzyme using molecular docking. The sequences and structures of SARS-CoV-2 M<sup>pro</sup> were compared with SARS-CoV M<sup>pro</sup> and MERS-CoV M<sup>pro</sup>. The identified lead molecules were further examined for their broad-spectrum inhibition potential against SARS-CoV M<sup>pro</sup> and MERS-CoV M<sup>pro</sup>.</p> </div> <div class="materialandmethods" title="sec"><span class="label" tagx="label" title="label">2</span><div class="title" tagx="title" title="title">
Material and methods</div> <div class="ligandpreparation" title="sec"><span class="label" tagx="label" title="label">2.1</span><div class="title" tagx="title" title="title">
Ligand preparation</div> <p id="p0020">The information about a set of thirty-eight phytochemicals from medicinal plants with antiviral activities was retrieved through literature search [<a href="#bb0070">14</a>]. The summary of the selected phytochemicals (class, plant source and antiviral activity) is provided in Suppl. Table 1. The two-dimensional structures of the phytochemicals were generated using Chemsketch and modelled into 3D using open Babel and the structure optimization was carried out with an MMFF94 force field [<a href="#bb0100">20</a>] using our previously defined protocol [<a href="#bb0105">21</a>]. These optimized structures were used for virtual screening. A set of twelve FDA approved antiviral drugs such as Raltegravir (CID54671008), Dolutegravir (CID54726191), Nelfinavir (CID64143), Lopinavir (CID92727), Zidovudine (CID35370), Nevirapine (CID4463), Simeprevir (24873435), Boceprevir (CID10324367), Zanamivir (CID60855), Oseltamivir (CID65028), Acyclovir (CID135398513) and Ganciclovir (CID135398740) were retrieved from PubChem database [<a href="#bb0110">22</a>].</p> </div> <div class="screeningofsmalldrug-likemolecules" title="sec"><span class="label" tagx="label" title="label">2.2</span><div class="title" tagx="title" title="title">
Screening of small drug-like molecules</div> <p id="p0025">The phytochemicals were screened based on physicochemical properties obeying Lipinski's rule of five (ROF) filters [<a href="#bb0115">23</a>] and further tested for in silico toxicity studies such as mutagenicity, tumorigenicity, reproductive effects and irritancy. The physicochemical properties of the phytochemicals were determined using DataWarrior program version 4.6.1 [<a href="#bb0120">24</a>].</p> </div> <div class="receptorpreparation" title="sec"><span class="label" tagx="label" title="label">2.3</span><div class="title" tagx="title" title="title">
Receptor preparation</div> <p id="p0030">The three-dimensional structures of SARS-CoV-2 M<sup>pro</sup>, SARS-CoV M<sup>pro</sup> and MERS-CoV M<sup>pro</sup> were retrieved from Protein Data Bank (PDB) (<a href="http://www.rcsb.org/">http://www.rcsb.org/</a>) using PDB IDs:<a href="pdb:6Y2F">6Y2F</a>, <a href="pdb:3TNT">3TNT</a> and <a href="pdb:5WKK">5WKK</a> at a resolution of 1.95Â Ã…, 1.59Â Ã… and 1.55Â Ã… respectively. The receptors were prepared for molecular docking using our previously defined protocol [<a href="#bb0125">25</a>]. The binding sites were defined by choosing grid boxes of suitable dimensions around the bound co-crystal ligand. The grid box dimensions for SARS-CoV-2 M<sup>pro</sup>, SARS-CoV M<sup>pro</sup> and MERS-CoV M<sup>pro</sup> are represented in <a href="#t0005">Table 1</a> . <div class="table-wrap_UNKNOWN" position="float" id="t0005"><span class="label" tagx="label" title="label">Table 1</span> </div></p><p>The grid box dimensions selected for molecular docking studies.</p>  <div tag="alt-text">
Table 1</div> <table frame="hsides" rules="groups"> <thead> <tr> <th rowspan="2">Target enzyme</th> <th colspan="3">Grid box dimension <hr /> </th> </tr> <tr> <th>Number of grid points (npts)</th> <th>Center (xyz coordinates)</th> <th>Grid point spacing (Ã…)</th> </tr> </thead> <tbody> <tr> <td>SARS-CoV-2 M<sup>pro</sup></td> <td>60Â Ã—Â 60Â Ã—Â 60</td> <td>11.476, âˆ’1.396. 21.127</td> <td align="char">0.375</td> </tr> <tr> <td>SARS-CoV M<sup>pro</sup></td> <td>65Â Ã—Â 65Â Ã—Â 65</td> <td>22.803, 40.132, âˆ’10.620</td> <td align="char">0.375</td> </tr> <tr> <td>MERS-CoV M<sup>pro</sup></td> <td>65Â Ã—Â 65Â Ã—Â 65</td> <td>âˆ’16.001, 25.308, 10.579</td> <td align="char">0.375</td> </tr> </tbody> </table>  <p /> </div> <div class="determinationofsequencepercentageidentity,multiplesequencealignmentandpairwisestructuralclustering" title="sec"><span class="label" tagx="label" title="label">2.4</span><div class="title" tagx="title" title="title">
Determination of sequence percentage identity, multiple sequence alignment and pairwise structural clustering</div> <p id="p0035">The sequence percentage identity of the SARS-CoV-2 M<sup>pro</sup> to SARS-CoV M<sup>pro</sup> and MERS-CoV M<sup>pro</sup> was determined using a standard protein Basic Local Alignment Search (BLASTp) tool (<a href="https://blast.ncbi.nlm.nih.gov/Blast.cgi?PAGE=Proteins">https://blast.ncbi.nlm.nih.gov/Blast.cgi?PAGE=Proteins</a>). Multiple sequence alignment of the three sequences were performed using CLUSTAL W algorithm [<a href="#bb0130">26</a>]. Pairwise structural clustering of SARS-CoV-2 M<sup>pro</sup>, SARS-CoV M<sup>pro</sup> and MERS-CoV M<sup>pro</sup> was analyzed using UCSF Chimera tool [<a href="#bb0135">27</a>].</p> </div> <div class="validationofdockingmethod" title="sec"><span class="label" tagx="label" title="label">2.5</span><div class="title" tagx="title" title="title">
Validation of docking method</div> <p id="p0040">To check the suitability of molecular docking parameters and algorithm to reproduce the native binding poses, a redocking experiment was performed using the co-crystal compound.</p> </div> <div class="moleculardocking" title="sec"><span class="label" tagx="label" title="label">2.6</span><div class="title" tagx="title" title="title">
Molecular docking</div> <p id="p0045">Molecular docking was executed using AutoDock4.2 software [<a href="#bb0140">28</a>]. Lamarckian Genetic Algorithm was used for performing molecular docking studies and the docking parameters were chosen from our previously defined protocol [<a href="#bb0105">21</a>]. A total number of fifty independent docking runs were performed for each compound. The conformational clustering of the poses was performed by considering a root mean square deviation (RMSD) of &amp;lt;2.0Â Ã…. The most favourable binding poses of the compounds were analyzed by choosing the lowest free energy of binding (Î"G) and the lowest inhibition constant (K<sub>i</sub>) which is calculated using the following equation (Eq. <a href="#fo0005">(1)</a>): </p><div class="disp-formula" title="disp-formula"><span class="label" tagx="label" title="label">(1)</span><div class="math_UNKNOWN"> <div class="msub_UNKNOWN"> <div class="mi_UNKNOWN">
K</div> <div class="mi_UNKNOWN">
i</div> </div> <div class="mo_UNKNOWN">
=</div> <div class="mtext_UNKNOWN">
exponential</div> <div class="mspace_UNKNOWN" /> <div class="mfenced_UNKNOWN"> <div class="mrow_UNKNOWN"> <div class="mi_UNKNOWN">
âˆ†G</div> <div class="mo_UNKNOWN">
/</div> <div class="mi_UNKNOWN">
RT</div> </div> </div></div></div>where âˆ†G is the binding energy in kcal/mol, R is the universal gas constant (1.987Â calK<sup>âˆ’1</sup>Â mol<sup>âˆ’1</sup>) and T is the temperature (298.15Â K).<p /> <p id="p0050">A stable complex is formed between a protein and ligand which exhibits more negative free energy of binding and low K<sub>i</sub> indicates high potency of an inhibitor [<a href="#bb0145">29</a>,<a href="#bb0150">30</a>]. The hydrogen bonds and hydrophobic interactions between the compounds and the target enzymes were studied using LigPlot+ v 1.4.5 [<a href="#bb0155">31</a>].</p> </div> </div> <div class="resultsanddiscussion" title="sec"><span class="label" tagx="label" title="label">3</span><div class="title" tagx="title" title="title">
Results and discussion</div> <div class="selectionofphytochemicalsforthestudy" title="sec"><span class="label" tagx="label" title="label">3.1</span><div class="title" tagx="title" title="title">
Selection of phytochemicals for the study</div> <p id="p0055">A total of 38 bioactive phytochemicals possessing antiviral activities were selected for the study. These compounds were chosen based on the previous reports of their potent antiviral effects against various pathogenic viruses such as adenovirus, influenza virus, respiratory syncytial virus, human cytomegalovirus, herpes simplex virus, poliovirus, varicella-zoster virus etc. (Suppl. Table 1). The compound set consists of different classes of phytochemicals including active flavonoids (<i>N</i>Â =Â 14), active organic acids (<i>N</i>Â =Â 5), active alkaloids (NÂ =Â 5), active essential oils (<i>N</i>Â =Â 3), active stilbenes (<i>N</i>Â =Â 6) and other phytoconstituents (NÂ =Â 5). The three-dimensional structures the compounds were modelled and optimized. A list of these phytochemicals is enumerated in <a href="#t0010">Table 2</a> . These optimized structures were used further for virtual screening and molecular docking studies. <div class="table-wrap_UNKNOWN" position="float" id="t0010"><span class="label" tagx="label" title="label">Table 2</span> </div></p><p>List of phytochemicals selected for virtual screening.</p>  <div tag="alt-text">
Table 2</div> <table frame="hsides" rules="groups"> <thead> <tr> <th>Class</th> <th>Phytochemicals</th> <th>Name</th> </tr> </thead> <tbody> <tr> <td rowspan="14">Flavonoids</td> <td>Cmpd1</td> <td>(+)-Catechin</td> </tr> <tr> <td>Cmpd2</td> <td>(âˆ’)-Epigallocatechin gallate (EGCG)</td> </tr> <tr> <td>Cmpd3</td> <td>(âˆ’)-Epicatechin gallate (ECG)</td> </tr> <tr> <td>Cmpd4</td> <td>(âˆ’)-Epigallocatechin (EGC)</td> </tr> <tr> <td>Cmpd5</td> <td>Rutin</td> </tr> <tr> <td>Cmpd6</td> <td>5,7-dimethoxyflavaN-4â€²-O-Î²-d-glucopyranoside</td> </tr> <tr> <td>Cmpd7</td> <td>5,7,3â€²-trihydroxy-flavaN-4â€²-O-Î²-d-glucopyranoside</td> </tr> <tr> <td>Cmpd8</td> <td>Genistein</td> </tr> <tr> <td>Cmpd9</td> <td>Baicalein</td> </tr> <tr> <td>Cmpd10</td> <td>Orientin</td> </tr> <tr> <td>Cmpd11</td> <td>Vitexin</td> </tr> <tr> <td>Cmpd12</td> <td>Chrysosplenol C</td> </tr> <tr> <td>Cmpd13</td> <td>Quercetin 3-rhamnoside (Q3R)</td> </tr> <tr> <td>Cmpd14</td> <td>Luteoforol</td> </tr> <tr> <td rowspan="5">Organic acids</td> <td>Cmpd15</td> <td>3,4-di-O-caffeoylquinic acid</td> </tr> <tr> <td>Cmpd16</td> <td>3,5-di-O-caffeoylquinic acid</td> </tr> <tr> <td>Cmpd17</td> <td>Raoulic acid</td> </tr> <tr> <td>Cmpd18</td> <td>Caffeic acid</td> </tr> <tr> <td>Cmpd19</td> <td>Chlorogenic acid</td> </tr> <tr> <td rowspan="5">Alkaloids</td> <td>Cmpd20</td> <td>Naphthoindozidine alkaloid</td> </tr> <tr> <td>Cmpd21</td> <td>7-demethoxytylophorine</td> </tr> <tr> <td>Cmpd22</td> <td>7-demethoxytylophorine N-oxide</td> </tr> <tr> <td>Cmpd23</td> <td>Sophoridine</td> </tr> <tr> <td>Cmpd24</td> <td>Lycorine</td> </tr> <tr> <td rowspan="3">Essential oils</td> <td>Cmpd25</td> <td>Himachalol</td> </tr> <tr> <td>Cmpd26</td> <td>Î±-himachalene</td> </tr> <tr> <td>Cmpd27</td> <td>Î²-himachalene</td> </tr> <tr> <td rowspan="6">Stilbenes</td> <td>Cmpd28</td> <td>Resveratrol</td> </tr> <tr> <td>Cmpd29</td> <td>Balanocarpol</td> </tr> <tr> <td>Cmpd30</td> <td>Shegansu B</td> </tr> <tr> <td>Cmpd31</td> <td>Gnetupendin B</td> </tr> <tr> <td>Cmpd32</td> <td>Gnetin D</td> </tr> <tr> <td>Cmpd33</td> <td>Isorhapontigenin</td> </tr> <tr> <td rowspan="5">Others</td> <td>Cmpd34</td> <td>Caesalmin B</td> </tr> <tr> <td>Cmpd35</td> <td>Bonducellpin D</td> </tr> <tr> <td>Cmpd36</td> <td>Chrysophanic acid (1,8-dihydroxy-3-methylanthraquiN)</td> </tr> <tr> <td>Cmpd37</td> <td>Emodin</td> </tr> <tr> <td>Cmpd38</td> <td>Hippomanin A</td> </tr> </tbody> </table>  <p /> </div> <div class="screeningofsmalldrug-likemolecules" title="sec"><span class="label" tagx="label" title="label">3.2</span><div class="title" tagx="title" title="title">
Screening of small drug-like molecules</div> <p id="p0060">From a total of 38 phytochemicals, 10 compounds (four active flavonoids, two active alkaloids, two active essential oils and two other phytoconstituents) were found to be orally bioactive with respect to ROF criterion (Molecular weight (MW) â‰¤500, cLogP (partition coefficient between n-octanol and water) â‰¤5, number of hydrogen bond donors (HBD) â‰¤5 and number of hydrogen bond acceptors (HBA) â‰¤10 [<a href="#bb0115">23</a>]) without any significant toxicity issues such as being non-mutagenic, non-tumourigenic, non-irritant and no adverse effects on reproductive health (<a href="#t0015">Table 3</a> ). These drug-like compounds were further taken for molecular docking studies. The drug-attrition rate in preclinical and clinical trials is quite high due to the poor pharmacokinetic studies [<a href="#bb0125">25</a>] and therefore initial screening of these drug-like molecules can increase the chances of passing through the clinics. <div class="table-wrap_UNKNOWN" position="float" id="t0015"><span class="label" tagx="label" title="label">Table 3</span> </div></p><p>Physicochemical properties of the compounds (asterisk indicates the compounds which passed the toxicity studies). a: Molecular weight, b: Partition coefficient between n-octanol and water, c: Hydrogen bond acceptor, d: Hydrogen bond donor, N: None, H: High, L: Low.</p>  <div tag="alt-text">
Table 3</div> <table frame="hsides" rules="groups"> <thead> <tr> <th>Compounds</th> <th>MW<sup>a</sup> (Da)</th> <th>clogP<sup>b</sup></th> <th>HBA<sup>c</sup></th> <th>HBD<sup>d</sup></th> <th>Mutagenic</th> <th>Tumourigenic</th> <th>Reproductive effective</th> <th>Irritant</th> </tr> </thead> <tbody> <tr> <td>Cmpd1*</td> <td align="char">290.270</td> <td align="char">1.5087</td> <td align="char">6</td> <td align="char">5</td> <td>N</td> <td>N</td> <td>N</td> <td>N</td> </tr> <tr> <td>Cmpd2</td> <td align="char">458.374</td> <td align="char">2.0543</td> <td align="char">11</td> <td align="char">8</td> <td>N</td> <td>N</td> <td>N</td> <td>N</td> </tr> <tr> <td>Cmpd3</td> <td align="char">442.375</td> <td align="char">2.4</td> <td align="char">10</td> <td align="char">7</td> <td>N</td> <td>N</td> <td>N</td> <td>N</td> </tr> <tr> <td>Cmpd4</td> <td align="char">306.269</td> <td align="char">1.163</td> <td align="char">7</td> <td align="char">6</td> <td>N</td> <td>N</td> <td>N</td> <td>N</td> </tr> <tr> <td>Cmpd5</td> <td align="char">610.519</td> <td align="char">âˆ’1.2573</td> <td align="char">16</td> <td align="char">10</td> <td>N</td> <td>N</td> <td>N</td> <td>N</td> </tr> <tr> <td>Cmpd6*</td> <td align="char">462.449</td> <td align="char">0.7178</td> <td align="char">10</td> <td align="char">4</td> <td>N</td> <td>N</td> <td>N</td> <td>N</td> </tr> <tr> <td>Cmpd7</td> <td align="char">450.395</td> <td align="char">âˆ’0.1793</td> <td align="char">11</td> <td align="char">7</td> <td>N</td> <td>N</td> <td>N</td> <td>N</td> </tr> <tr> <td>Cmpd8</td> <td align="char">270.239</td> <td align="char">1.6272</td> <td align="char">5</td> <td align="char">3</td> <td>H</td> <td>H</td> <td>H</td> <td>N</td> </tr> <tr> <td>Cmpd9*</td> <td align="char">270.239</td> <td align="char">2.3357</td> <td align="char">5</td> <td align="char">3</td> <td>N</td> <td>N</td> <td>N</td> <td>N</td> </tr> <tr> <td>Cmpd10</td> <td align="char">448.379</td> <td align="char">âˆ’0.4237</td> <td align="char">11</td> <td align="char">8</td> <td>H</td> <td>N</td> <td>N</td> <td>N</td> </tr> <tr> <td>Cmpd11</td> <td align="char">432.380</td> <td align="char">âˆ’0.078</td> <td align="char">10</td> <td align="char">7</td> <td>H</td> <td>N</td> <td>N</td> <td>N</td> </tr> <tr> <td>Cmpd12</td> <td align="char">360.317</td> <td align="char">2.1238</td> <td align="char">8</td> <td align="char">3</td> <td>H</td> <td>N</td> <td>N</td> <td>N</td> </tr> <tr> <td>Cmpd13</td> <td align="char">448.379</td> <td align="char">0.5798</td> <td align="char">11</td> <td align="char">7</td> <td>N</td> <td>N</td> <td>N</td> <td>N</td> </tr> <tr> <td>Cmpd14*</td> <td align="char">290.270</td> <td align="char">1.6348</td> <td align="char">6</td> <td align="char">5</td> <td>N</td> <td>N</td> <td>N</td> <td>N</td> </tr> <tr> <td>Cmpd15</td> <td align="char">516.454</td> <td align="char">0.7977</td> <td align="char">12</td> <td align="char">7</td> <td>N</td> <td>N</td> <td>N</td> <td>N</td> </tr> <tr> <td>Cmpd16</td> <td align="char">516.454</td> <td align="char">0.7977</td> <td align="char">12</td> <td align="char">7</td> <td>N</td> <td>N</td> <td>N</td> <td>N</td> </tr> <tr> <td>Cmpd17</td> <td align="char">370.575</td> <td align="char">8.2146</td> <td align="char">2</td> <td align="char">1</td> <td>N</td> <td>N</td> <td>N</td> <td>N</td> </tr> <tr> <td>Cmpd18</td> <td align="char">180.159</td> <td align="char">0.7285</td> <td align="char">4</td> <td align="char">3</td> <td>H</td> <td>H</td> <td>H</td> <td>N</td> </tr> <tr> <td>Cmpd19</td> <td align="char">354.310</td> <td align="char">âˆ’0.7685</td> <td align="char">9</td> <td align="char">6</td> <td>N</td> <td>N</td> <td>N</td> <td>N</td> </tr> <tr> <td>Cmpd20</td> <td align="char">353.460</td> <td align="char">3.5777</td> <td align="char">4</td> <td align="char">0</td> <td>N</td> <td>H</td> <td>N</td> <td>H</td> </tr> <tr> <td>Cmpd21</td> <td align="char">363.456</td> <td align="char">4.0868</td> <td align="char">4</td> <td align="char">0</td> <td>L</td> <td>H</td> <td>N</td> <td>N</td> </tr> <tr> <td>Cmpd22</td> <td align="char">379.455</td> <td align="char">3.1134</td> <td align="char">5</td> <td align="char">0</td> <td>L</td> <td>H</td> <td>N</td> <td>N</td> </tr> <tr> <td>Cmpd23*</td> <td align="char">248.369</td> <td align="char">1.7074</td> <td align="char">3</td> <td align="char">0</td> <td>N</td> <td>N</td> <td>N</td> <td>N</td> </tr> <tr> <td>Cmpd24*</td> <td align="char">287.314</td> <td align="char">1.2078</td> <td align="char">5</td> <td align="char">2</td> <td>N</td> <td>N</td> <td>N</td> <td>N</td> </tr> <tr> <td>Cmpd25*</td> <td align="char">222.370</td> <td align="char">3.5349</td> <td align="char">1</td> <td align="char">1</td> <td>N</td> <td>N</td> <td>N</td> <td>N</td> </tr> <tr> <td>Cmpd26</td> <td align="char">204.356</td> <td align="char">4.3321</td> <td align="char">0</td> <td align="char">0</td> <td>N</td> <td>N</td> <td>N</td> <td>L</td> </tr> <tr> <td>Cmpd27*</td> <td align="char">204.356</td> <td align="char">4.4247</td> <td align="char">0</td> <td align="char">0</td> <td>N</td> <td>N</td> <td>N</td> <td>N</td> </tr> <tr> <td>Cmpd28</td> <td align="char">228.246</td> <td align="char">2.8295</td> <td align="char">3</td> <td align="char">3</td> <td>H</td> <td>N</td> <td>H</td> <td>N</td> </tr> <tr> <td>Cmpd29</td> <td align="char">470.476</td> <td align="char">3.3075</td> <td align="char">7</td> <td align="char">6</td> <td>N</td> <td>N</td> <td>N</td> <td>N</td> </tr> <tr> <td>Cmpd30</td> <td align="char">514.528</td> <td align="char">4.6839</td> <td align="char">8</td> <td align="char">5</td> <td>N</td> <td>N</td> <td>N</td> <td>N</td> </tr> <tr> <td>Cmpd31</td> <td align="char">380.395</td> <td align="char">3.884</td> <td align="char">6</td> <td align="char">5</td> <td>N</td> <td>N</td> <td>H</td> <td>N</td> </tr> <tr> <td>Cmpd32</td> <td align="char">470.476</td> <td align="char">4.4782</td> <td align="char">7</td> <td align="char">6</td> <td>N</td> <td>N</td> <td>H</td> <td>N</td> </tr> <tr> <td>Cmpd33</td> <td align="char">258.272</td> <td align="char">2.7595</td> <td align="char">4</td> <td align="char">3</td> <td>N</td> <td>N</td> <td>H</td> <td>N</td> </tr> <tr> <td>Cmpd34*</td> <td align="char">388.458</td> <td align="char">2.5856</td> <td align="char">6</td> <td align="char">1</td> <td>N</td> <td>N</td> <td>N</td> <td>N</td> </tr> <tr> <td>Cmpd35*</td> <td align="char">404.457</td> <td align="char">1.7335</td> <td align="char">7</td> <td align="char">2</td> <td>N</td> <td>N</td> <td>N</td> <td>N</td> </tr> <tr> <td>Cmpd36</td> <td align="char">254.240</td> <td align="char">2.6859</td> <td align="char">4</td> <td align="char">2</td> <td>H</td> <td>N</td> <td>N</td> <td>H</td> </tr> <tr> <td>Cmpd37</td> <td align="char">270.239</td> <td align="char">2.3402</td> <td align="char">5</td> <td align="char">3</td> <td>H</td> <td>H</td> <td>H</td> <td>H</td> </tr> <tr> <td>Cmpd38</td> <td align="char">634.454</td> <td align="char">0.0527</td> <td align="char">18</td> <td align="char">11</td> <td>N</td> <td>N</td> <td>N</td> <td>N</td> </tr> <tr> <td>Control</td> <td align="char">594.687</td> <td align="char">1.7119</td> <td align="char">12</td> <td align="char">4</td> <td>N</td> <td>N</td> <td>N</td> <td>N</td> </tr> </tbody> </table>  <p /> </div> <div class="comparativeanalysisofsars-cov-2mpro,sars-covmproandmers-covmproatthesequenceandstructurallevel" title="sec"><span class="label" tagx="label" title="label">3.3</span><div class="title" tagx="title" title="title">
Comparative analysis of SARS-CoV-2 M<sup>pro</sup>, SARS-CoV M<sup>pro</sup> and MERS-CoV M<sup>pro</sup> at the sequence and structural level</div> <p id="p0065">The primary sequences of SARS-CoV-2 M<sup>pro</sup> was compared with that of SARS-CoV M<sup>pro</sup> and MERS-CoV M<sup>pro</sup> and it was found that SARS-CoV-2 M<sup>pro</sup> shares identity percentages of 96.08 and 50.65 with that of SARS-CoV M<sup>pro</sup> and MERS-CoV M<sup>pro</sup> respectively (<a href="#t0020">Table 4</a> ). The MSA results show the conservation of residues in the three domains-I (residues 1â€"99), II (residues 100â€"182) and III (residues 199â€"306) of the SARS-CoV-2 M<sup>pro</sup> enzyme which includes catalytic dyad residues His41-Cys145 located in a cleft between domains I and II along with canonical oxyanion hole residues Gly143, Ser144 and Cys145 (<a href="#f0005">Fig. 1</a> ). Domains I and II have a typical chymotrypsin-like two-Î²-barrel fold. Domain III possesses a globular structure consisting of five Î±-helices which is connected to Domain II by a loop of residues 183â€"198 [<a href="#bb0160">32</a>]. The pairwise structural imposition of SARS-CoV-2 M<sup>pro</sup> and SARS-CoV M<sup>pro</sup> yields an RMSD value of 0.517Â Ã… while an RMSD value of 0.817Â Ã… was obtained when SARS-CoV-2 M<sup>pro</sup> was superimposed on MERS-CoV M<sup>pro</sup> (<a href="#f0010">Fig. 2</a> ). This indicates that SARS-CoV-2 M<sup>pro</sup> is structurally more close to SARS-CoV M<sup>pro</sup> as compared to MERS-CoV M<sup>pro</sup>. This comparative study at the sequence and structural level can be exploited for the design of broad-spectrum inhibitors which can block viral infection in host cells. <div class="table-wrap_UNKNOWN" position="float" id="t0020"><span class="label" tagx="label" title="label">Table 4</span> </div></p><p>Standard Protein BLAST result using SARS-CoV-2 M<sup>pro</sup> as a query sequence.</p>  <div tag="alt-text">
Table 4</div> <table frame="hsides" rules="groups"> <thead> <tr> <th>Subject sequence</th> <th>Maximum score</th> <th>Total score</th> <th>Query coverage</th> <th>E value</th> <th>Percent identity</th> </tr> </thead> <tbody> <tr> <td>SARS-CoV M<sup>pro</sup></td> <td align="char">623</td> <td align="char">623</td> <td align="char">100%</td> <td>0.0</td> <td align="char">96.08%</td> </tr> <tr> <td>MERS-CoV M<sup>pro</sup></td> <td align="char">322</td> <td align="char">322</td> <td align="char">100%</td> <td>1eâˆ’114</td> <td align="char">50.65%</td> </tr> </tbody> </table>  <div class="fig" title="fig"> <div class="figure" title="figure"><a href="http://doi.org/"><span class="label" tagx="label" title="label">Fig. 1</span></a></div>   <p>Sequence and structural analysis of SARS-CoV-2 M<sup>pro</sup>. (A) three-dimensional structure of SARS-CoV-2 M<sup>pro</sup> consists of three domains-I (orange-red), II (yellow) and III (forest green) where domain II and III are connected by a loop (cornflower blue), (B) Multiple Sequence alignment (MSA) of SARS-CoV-2 M<sup>pro</sup>, SARS-CoV M<sup>pro</sup> and MERS-CoV M<sup>pro</sup>. The red box with white characters indicates strict identity whereas yellow box with red characters corresponds to semi-conserved residues. The secondary structure elements such as Î±-helices and 310-helices (Î·) are displayed as squiggles and Î²-strands and strict Î²-turns are rendered as arrows and TT letters respectively. (For interpretation of the references to color in this figure legend, the reader is referred to the web version of this article.)</p>   </div> <div class="fig" title="fig"> <div class="figure" title="figure"><a href="http://doi.org/"><span class="label" tagx="label" title="label">Fig. 2</span></a></div>   <p>Structural clustering- (A) SARS-CoV-2 M<sup>pro</sup> (tan) and SARS-CoV M<sup>pro</sup> (cyan), (B) SARS-CoV-2 M<sup>pro</sup> (tan) and MERS-CoV M<sup>pro</sup> (cyan). (For interpretation of the references to color in this figure legend, the reader is referred to the web version of this article.)</p>   </div> <p /> </div> <div class="bindinginteractionstudiesofdrug-likemoleculeswithsars-cov-2mpro" title="sec"><span class="label" tagx="label" title="label">3.4</span><div class="title" tagx="title" title="title">
Binding interaction studies of drug-like molecules with SARS-CoV-2 M<sup>pro</sup></div> <p id="p0070">The molecular docking protocol and algorithm was validated through the redocking experiment. The redocking result of co-crystal compound (6OK) shows an RMSD value of 3.603Â Ã… between the docked and native co-crystal position. This small deviation indicates that the docking protocols and parameters used in the study can reliably estimate the biological conformations of the compounds [<a href="#bb0165">33</a>].</p> <p id="p0075">The ten selected drug-like small molecules were docked into the active site pocket of SARS-CoV-2 M<sup>pro</sup>. The molecular docking results are shown in <a href="#t0025">Table 5</a> . The docking scores were bench-marked using the standard inhibitor, Î±-ketoamide 13 b (6OK). The Î±-ketoamide 13 b is a broad-spectrum inhibitor with an IC<sub>50</sub> value of 0.67Â Â±Â 0.18Â Î¼M, 0.90Â Â±Â 0.29Â Î¼M and 0.58Â Â±Â 0.22Â Î¼M respectively against purified recombinant SARS-CoV-2 M<sup>pro</sup>, SARS-CoV M<sup>pro</sup> and MERS-CoV M<sup>pro</sup> [<a href="#bb0040">8</a>]. On comparing the binding energies and inhibition constants with that of the standard inhibitor, we have shortlisted three lead molecules viz., Bonducellpin D, 5,7-dimethoxyflavanone-4â€²-O-Î²-d-glucopyranoside and Caesalmin B. Bonducellpin D and Caesalmin B are terpenoids isolated from the seeds of traditional Chinese medicinal plant <i>Caesalpinia minax</i> and exhibit in vitro inhibitory activities against Parainfluenza-3 (PI-3) virus. [<a href="#bb0170">34</a>] The flavonoid 5,7-dimethoxyflavanone-4â€²-O-Î²-d-glucopyranoside has previously been reported to have antiviral activity against PI-3 [<a href="#bb0175">35</a>]. The molecular interactions of LigPLot results are represented in <a href="#t0030">Table 6</a> . The best-ranked lead molecule i.e., Bonducellpin D interacts with the enzyme target with a binding energy of âˆ’9.28Â kcal/mol and inhibition constant of 156.75Â nM. Bonducellpin D establishes four hydrogen bonds with residues Glu166 and Thr190 and hydrophobic interactions via eight residues (Met49, His164, Met165, Pro168, Asp187, Arg188, Gln189 and Gln192) (<a href="#f0015">Fig. 3</a>A). The second lead molecule i.e., 5,7-dimethoxyflavanone-4â€²-O-Î²-d-glucopyranoside interacts with the target enzyme with a binding energy of âˆ’9.23Â kcal/mol and inhibition constant of 170.31Â nM. This interaction is strengthed by the establishment of five hydrogen bonds with residues Glu166, Thr190 and Gln192 and with the involvement of thirteen residues (Phe140, Leu141, Asn142, Gly143, Ser144, Cys145, His164, Met165, Leu167, Pro168, His172, Arg188 and Gln189) contributing to hydrophobic interactions (<a href="#f0015">Fig. 3</a>B). The third lead molecule- Caesalmin B interacts with SARS-CoV-2 M<sup>pro</sup> with a binding energy of âˆ’8.82Â kcal/mol and inhibition constant of 342.79Â nM. The molecular interaction is facilitated through four hydrogen bonds with residues Glu166, Thr190 and Gln192 and hydrophobic interactions via ten residues (His41, Met49, Tyr54, Cys145, His164, Met165, Leu167, Asp187, Arg188 and Glu189) (<a href="#f0015">Fig. 3</a>C). The standard inhibitor interacts with SARS-CoV-2 M<sup>pro</sup> with a binding energy of âˆ’8.24Â kcal/mol and inhibition constant of 905.88Â nM. The binding interaction is mediated through four hydrogen bonds with residues Asn142, Cys145 and Glu166, and hydrophobic interactions via fourteen residues (Thr26, His41, Phe140, Leu141, Gly143, Ser144, His163, His164, Met165, Pro168, Asp187, Gln189, Thr190 and Gln192) (<a href="#f0015">Fig. 3</a>D). Interestingly, the residues His41 and Cys145 which form catalytic dyad residues are also found interacting with the inhibitor. Thus all the three lead molecules have better binding affinity to SARS-CoV-2 M<sup>pro</sup> compared to the standard inhibitor. <div class="table-wrap_UNKNOWN" position="float" id="t0025"><span class="label" tagx="label" title="label">Table 5</span> </div></p><p>Molecular docking result for selected compounds and control against SARS-CoV-2 M<sup>pro</sup>.</p>  <div tag="alt-text">
Table 5</div> <table frame="hsides" rules="groups"> <thead> <tr> <th>Compounds</th> <th>Name</th> <th>Structure</th> <th>Binding energy (kcal/mol)</th> <th>Inhibition constant (nM)</th> </tr> </thead> <tbody> <tr> <td>Cmpd1</td> <td>(+)-Catechin</td> <td><span class="inline-graphic" title="inline-graphic"> <div tag="alt-text">
Image 1</div></span></td> <td align="char">âˆ’7.86</td> <td align="char">1720</td> </tr> <tr> <td>Cmpd6</td> <td>5,7-dimethoxyflavaN-4â€²-O-Î²-d-glucopyranoside</td> <td><span class="inline-graphic" title="inline-graphic"> <div tag="alt-text">
Image 2</div></span></td> <td align="char">âˆ’9.23</td> <td align="char">170.31</td> </tr> <tr> <td>Cmpd9</td> <td>Baicalein</td> <td><span class="inline-graphic" title="inline-graphic"> <div tag="alt-text">
Image 3</div></span></td> <td align="char">âˆ’6.51</td> <td align="char">16,950</td> </tr> <tr> <td>Cmpd14</td> <td>Luteoforol</td> <td><span class="inline-graphic" title="inline-graphic"> <div tag="alt-text">
Image 4</div></span></td> <td align="char">âˆ’7.02</td> <td align="char">7100</td> </tr> <tr> <td>Cmpd23</td> <td>Sophoridine</td> <td><span class="inline-graphic" title="inline-graphic"> <div tag="alt-text">
Image 5</div></span></td> <td align="char">âˆ’6.76</td> <td align="char">11,120</td> </tr> <tr> <td>Cmpd24</td> <td>Lycorine</td> <td><span class="inline-graphic" title="inline-graphic"> <div tag="alt-text">
Image 6</div></span></td> <td align="char">âˆ’7.67</td> <td align="char">2380</td> </tr> <tr> <td>Cmpd25</td> <td>Himachalol</td> <td><span class="inline-graphic" title="inline-graphic"> <div tag="alt-text">
Image 7</div></span></td> <td align="char">âˆ’7.00</td> <td align="char">7390</td> </tr> <tr> <td>Cmpd27</td> <td>Î²-himachalene</td> <td><span class="inline-graphic" title="inline-graphic"> <div tag="alt-text">
Image 8</div></span></td> <td align="char">âˆ’5.80</td> <td align="char">55,970</td> </tr> <tr> <td>Cmpd34</td> <td>Caesalmin B</td> <td><span class="inline-graphic" title="inline-graphic"> <div tag="alt-text">
Image 9</div></span></td> <td align="char">âˆ’8.82</td> <td align="char">342.79</td> </tr> <tr> <td>Cmpd35</td> <td>Bonducellpin D</td> <td><span class="inline-graphic" title="inline-graphic"> <div tag="alt-text">
Image 10</div></span></td> <td align="char">âˆ’9.28</td> <td align="char">156.75</td> </tr> <tr> <td>Control</td> <td>Î±-ketoamide 13b</td> <td><span class="inline-graphic" title="inline-graphic"> <div tag="alt-text">
Image 11</div></span></td> <td align="char">âˆ’8.24</td> <td align="char">905.88</td> </tr> </tbody> </table>  <div class="table-wrap_UNKNOWN" position="float" id="t0030"><span class="label" tagx="label" title="label">Table 6</span> <p>LigPlot analysis for top three lead compounds along with the control against SARS-CoV-2 M<sup>pro</sup>.</p>  <div tag="alt-text">
Table 6</div> <table frame="hsides" rules="groups"> <thead> <tr> <th>Compounds</th> <th>Name</th> <th>Hydrogen bonds</th> <th>Hydrophobic interactions</th> </tr> </thead> <tbody> <tr> <td>Cmpd35</td> <td>Bonducellpin D</td> <td>O2â€¦..O(Glu166) (2.83Â Ã…)<br /><br />O2â€¦..N(Glu166) (2.91Â Ã…)<br /><br />O4â€¦..O(Glu166) (2.61Â Ã…)<br /><br />O6â€¦..N(Thr190) (2.92Â Ã…)</td> <td>Met49, His164, Met165, Pro168, Asp187, Arg188, Gln189 and Gln192 (<i>N</i>Â =Â 8)</td> </tr> <tr> <td>Cmpd6</td> <td>5,7-dimethoxyflavaN-4â€²-O-Î²-d-glucopyranoside</td> <td>O8â€¦..O(Glu166) (2.76Â Ã…)<br /><br />O1â€¦..N(Glu166) (3.22Â Ã…)<br /><br />O7â€¦..N(Thr190) (3.03Â Ã…)<br /><br />O7â€¦..N(Thr190) (2.44Â Ã…)<br /><br />O9â€¦..O(Gln192) (2.91Â Ã…)</td> <td>Phe140, Leu141, Asn142, Gly143 Ser144, Cys145, His164, Met165, Leu167, Pro168, His172, Arg188 and Gln189 (<i>N</i>Â =Â 13)</td> </tr> <tr> <td>Cmpd34</td> <td>Caesalmin B</td> <td>O2â€¦..N(Glu166) (3.32Â Ã…)<br /><br />O2â€¦..O(Glu166) (2.46Â Ã…)<br /><br />O6â€¦..N(Thr190) (3.01Â Ã…)<br /><br />O6â€¦..NE2(Gln192) (2.87Â Ã…)</td> <td>Met49, His41, Tyr54, Cys145, His164, Met165, Leu167, Asp187, Arg188 and Glu189 (NÂ =Â 10)</td> </tr> <tr> <td>Control</td> <td>Î±-ketoamide 13b</td> <td>N23â€¦..OD1(Asn142) (2.83Â Ã…)<br /><br />O37â€¦..SG(Cys145) (3.31Â Ã…)<br /><br />O41â€¦..N(Glu166) (3.12Â Ã…)<br /><br />O40â€¦..N(Glu166) (2.98Â Ã…)</td> <td>Thr26, His41, Gly143, Phe140, Leu141, Ser144, His163, His164, Met165, Pro168, Asp187, Gln189, Thr190 and Gln192 (NÂ =Â 14)</td> </tr> </tbody> </table> </div> <div class="fig" title="fig"> <div class="figure" title="figure"><a href="http://doi.org/"><span class="label" tagx="label" title="label">Fig. 3</span></a></div>   <p>Binding poses and molecular interactions between lead compounds and SARS-CoV-2 M<sup>pro</sup>. (A) Bonducellpin D, (B) 5,7-dimethoxyflavanone-4â€²-O-Î²-d-glucopyranoside, (C) Caesalmin B, (D) Î±-ketoamide 13b (Control). The binding poses display the target enzyme in ribbon form with structural domains-I (orange-red), II (yellow) and III (forest green) where domain II and III are connected by a loop (cornflower blue) and the bound compounds are rendered as ball-and-stick (purple). The molecular interactions show hydrogen bonds as green dashed lines and hydrophobic interactions as semi-arcs with red eyelashes. (For interpretation of the references to color in this figure legend, the reader is referred to the web version of this article.)</p>   </div> <p /> </div> <div class="bindinginteractionstudiesoftheleadcompoundswithsars-covmproandmers-covmpro" title="sec"><span class="label" tagx="label" title="label">3.5</span><div class="title" tagx="title" title="title">
Binding interaction studies of the lead compounds with SARS-CoV M<sup>pro</sup> and MERS-CoV M<sup>pro</sup></div> <p id="p0080">Due to the close similarity of SARS-CoV-2 M<sup>pro</sup> to SARS-CoV M<sup>pro</sup> and MERS-CoV M<sup>pro</sup> at the structural level, the identified lead molecules may have broad-spectrum inhibitory activity and therefore, the binding affinities of the lead molecules against the other two target enzymes were studied. The binding energies and inhibition constants of the compounds against SARS-CoV M<sup>pro</sup> and MERS-CoV M<sup>pro</sup> are shown in <a href="#t0035">Table 7</a> . The best-ranked lead molecule i.e., Bonducellpin D exhibits binding energies and inhibition constants of âˆ’8.64Â kcal/mol and 467.11Â nM; âˆ’8.93Â kcal/mol and 284.86Â nM against SARS-CoV M<sup>pro</sup> and MERS-CoV M<sup>pro</sup> respectively. It binds to SARS-CoV M<sup>pro</sup> by establishing two hydrogen bonds with Gln189 and hydrophobic interacting residues include His41, Cys44, Met49, Tyr54, Asn142, Cys145, His164, Met165, Glu166, Asp187 and Arg188 (<i>N</i>Â =Â 11) (<a href="#f0020">Fig. 4</a>A). Bonducellpin D also shows good molecular interaction with MERS-CoV M<sup>pro</sup> using four hydrogen bonds with residues His41, Ser147, Cys148 and Glu169 and residues such as Met25, Leu49, Phe143, Leu144, Cys145, Gly146, His166, Gln167, Met168 and Gln192 (<i>N</i>Â =Â 10) participate in hydrophobic interactions (<a href="#f0025">Fig. 5</a>A). With binding energies and inhibition constants of âˆ’8.94Â kcal/mol and 282.15Â nM; âˆ’8.55Â kcal/mol and 539.13Â nM against SARS-CoV M<sup>pro</sup> and MERS-CoV M<sup>pro</sup> respectively, the second lead molecule i.e., 5,7-dimethoxyflavanone-4â€²-O-Î²-d-glucopyranoside also shows broad-spectrum antiviral activities. 5,7-dimethoxyflavanone-4â€²-O-Î²-d-glucopyranoside shows favourable interactions with SARS-CoV M<sup>pro</sup> through seven hydrogen bonds with His163, Glu166, Thr190 and Gln192 and hydrophobic interactions via residues Phe140, Leu141, Gly143, Ser144, Cys145, Met165, Leu167, Pro168, His172, Gln189 and Ala191 (<i>N</i>Â =Â 11) (<a href="#f0020">Fig. 4</a>B). It also exhibits good binding to MERS-CoV M<sup>pro</sup> through four hydrogen bonds via residues Gly146, Gln192 and Gln195 and the interaction is further strengthened through hydrophobic interactions via Met25, His41, Leu49, Cys148, Gln167, Met168, Glu169, Leu170, Ala171, Lys191, Val193 and His194 (<i>N</i>Â =Â 12) (<a href="#f0025">Fig. 5</a>B). The third lead compound- Caesalmin B shows binding energies and inhibition constants of âˆ’8.71Â kcal/mol and 412.24Â nM; âˆ’9.49Â kcal/mol and 111.50Â nM against SARS-CoV M<sup>pro</sup> and MERS-CoV M<sup>pro</sup> respectively. Caesalmin B shows optimum binding to SARS-CoV M<sup>pro</sup> by forming two hydrogen bonds with residues Gly143 and Glu166 and hydrophobic interactions via residues His41, Leu141, Asn142, Ser144, Cys145, His163, His164, Met165 and Gln189 (<i>N</i>Â =Â 9) (<a href="#f0020">Fig. 4</a>C). It also exhibits good binding to MERS-CoV M<sup>pro</sup> by establishing three hydrogen bonds with residues Cys145, Cys148 and His166 and hydrophobic interactions via residues Met25, Thr26, Leu27, Phe143, Leu144, Gly146, Ser147, Gln167, Met168, Glu169 and Gln192 (NÂ =Â 11) (<a href="#f0025">Fig. 5</a>C). The control shows binding energies and inhibition constants of âˆ’8.62Â kcal/mol and 482.81Â nM; âˆ’11.36Â kcal/mol and 4.75Â nM against SARS-CoV M<sup>pro</sup> and MERS-CoV M<sup>pro</sup> respectively. The interaction between the control and SARS-CoV M<sup>pro</sup> is mediated through two hydrogen bonds with Glu166 and Gln189 and hydrophobic interactions through residues-Thr25, His41, Val42, Cys44, Met49, Tyr54, Leu141, Asn142, Gly143, Ser144, Cys145, His163, His164, Met165, Leu167, Asp187 and Thr190 (<i>N</i>Â =Â 17) (<a href="#f0020">Fig. 4</a>D). It also shows good binding to MERS-CoV M<sup>pro</sup> which involves seven hydrogen bonds with Cys145, Ser147, Cys148, Gln167 and Glu169 and hydrophobic interactions via residues Met25, Thr26, Leu27, His41, Phe143, Leu144, Gly146, His166, Met168, Leu170, Ala171, Gln192, Val193, His194 and Gln195 (<i>N</i>Â =Â 15) (<a href="#f0025">Fig. 5</a>D). <div class="table-wrap_UNKNOWN" position="float" id="t0035"><span class="label" tagx="label" title="label">Table 7</span> </div></p><p>Molecular docking results for top 3 leads and control against SARS-CoV M<sup>pro</sup> and MERS-CoV M<sup>pro</sup>.</p>  <div tag="alt-text">
Table 7</div> <table frame="hsides" rules="groups"> <thead> <tr> <th colspan="2"> <hr /> </th> <th colspan="2">SARS-CoV M<sup>pro</sup><hr /> </th> <th colspan="2">MERS-CoV M<sup>pro</sup><hr /> </th> </tr> <tr> <th>Compounds</th> <th>Name</th> <th>Binding energy (kcal/mol)</th> <th>Inhibition constant (nM)</th> <th>Binding energy (kcal/mol)</th> <th>Inhibition constant (nM)</th> </tr> </thead> <tbody> <tr> <td>Cmpd35</td> <td>Bonducellpin D</td> <td align="char">âˆ’8.66</td> <td align="char">467.11</td> <td align="char">âˆ’8.93</td> <td align="char">284.86</td> </tr> <tr> <td>Cmpd6</td> <td>5,7-dimethoxyflavaN-4â€²-O-Î²-d-glucopyranoside</td> <td align="char">âˆ’8.94</td> <td align="char">282.15</td> <td align="char">âˆ’8.55</td> <td align="char">539.13</td> </tr> <tr> <td>Cmpd34</td> <td>Caesalmin B</td> <td align="char">âˆ’8.71</td> <td align="char">412.24</td> <td align="char">âˆ’9.49</td> <td align="char">111.50</td> </tr> <tr> <td>control</td> <td>Î±-ketoamide 13b</td> <td align="char">âˆ’8.62</td> <td align="char">482.81</td> <td align="char">âˆ’11.36</td> <td align="char">4.75</td> </tr> </tbody> </table>  <div class="fig" title="fig"> <div class="figure" title="figure"><a href="http://doi.org/"><span class="label" tagx="label" title="label">Fig. 4</span></a></div>   <p>Binding pose and molecular interaction between lead compounds and SARS-CoV M<sup>pro</sup>. (A) Bonducellpin D, (B) 5,7-dimethoxyflavanone-4â€²-O-Î²-d-glucopyranoside, (C) Caesalmin B, (D) Î±-ketoamide 13b (Control). The binding poses represent the target enzyme as ribbon where helices, sheets and loops are indicated by orange-red, purple and grey respectively and the bound compounds as ball-and-stick (cornflower blue). The molecular interactions are represented by the green dashed lines for hydrogen bonds and semi-arcs with red eyelashes for hydrophobic interactions. (For interpretation of the references to color in this figure legend, the reader is referred to the web version of this article.)</p>   </div> <div class="fig" title="fig"> <div class="figure" title="figure"><a href="http://doi.org/"><span class="label" tagx="label" title="label">Fig. 5</span></a></div>   <p>Molecular interaction between lead compounds and MERS-CoV M<sup>pro</sup>. (A) Bonducellpin D, (B) 5,7-dimethoxyflavanone-4â€²-O-Î²-d-glucopyranoside, (C) Caesalmin B, (D) Î±-ketoamide 13b (Control). The binding poses represent the target enzyme as ribbon where helices, sheets and loops are indicated by orange-red, purple and grey respectively and the bound compounds as ball-and-stick (cornflower blue). The molecular interactions are represented by the green dashed lines for hydrogen bonds and semi-arcs with red eyelashes for hydrophobic interactions. (For interpretation of the references to color in this figure legend, the reader is referred to the web version of this article.)</p>   </div> <p /> </div> <div class="comparisonofbindingaffinityoftheleadmoleculeswithfda-approvedantiviraldrugs" title="sec"><span class="label" tagx="label" title="label">3.6</span><div class="title" tagx="title" title="title">
Comparison of binding affinity of the lead molecules with FDA-approved antiviral drugs</div> <p id="p0085">The binding energies and inhibition constants of the phytochemicals with the SARS-CoV-2 M<sup>pro</sup> enzyme were compared with that of a set of twelve FDA approved antiviral drugs-a) Viral integrase inhibitors (Raltegravir and Dolutegravir) b) HIV-1 protease inhibitors (Nelfinavir and Lopinavir) c) HIV-1 reverse transcriptase inhibitors (Zidovudine and Nevirapine) d) HCV NS3/NS4B protease inhibitors (Simeprevir and Boceprevir) e) Neuraminidase inhibitors (Zanamivir and Oseltamivir) and f) HSV-1 thymidine kinase inhibitors (Acyclovir and Ganciclovir) (Suppl. Table 2). The results show that the binding energies and inhibition constant values of the phytochemicals were lower as compared to the majority of the approved antiviral drugs except for Nelfinavir (âˆ’9.54Â kcal/mol), Boceprevir (âˆ’9.3Â kcal/mol) and Simeprevir (âˆ’11.1Â kcal/mol) which indicates that these phytochemicals have higher binding affinity to the target enzyme as compared to the antiviral drugs.</p> </div> </div> <div class="conclusion" title="sec"><span class="label" tagx="label" title="label">4</span><div class="title" tagx="title" title="title">
Conclusion</div> <p id="p0090">With the exponential increase in the mortality rate and lack of therapeutic interventions for the treatment of SARS-CoV-2 infection in humans, the discovery of novel drug molecules is crucial. SARS-CoV-2 M<sup>pro</sup> is a well-characterized drug target and its recent structural elucidation through X-ray crystallography has opened an avenue for structure-based drug design. Herein, we have explored a small library of phytochemicals with previously reported antiviral properties for the identification of small molecular inhibitors against SARS-CoV-2 M<sup>pro</sup> using a computational approach. We identified three lead molecules- Bonducellpin D, 5,7-dimethoxyflavanone-4â€²-O-Î²-d-glucopyranoside and Caesalmin B which exhibit higher binding affinities as compared to the control. These lead molecules also demonstrate broad-spectrum antiviral activities against SARS-CoV M<sup>pro</sup> and MERS-CoV M<sup>pro</sup>. The current findings need further validations through in vitro and in vivo studies for developing into drug candidate molecules.</p> </div> <div class="COI-statement" title="COI-statement"> <div class="title" tagx="title" title="title">
Declaration of competing interest</div> <p id="p0095">The authors report no conflicts of interest in this work.</p> </div> </div> <div class="back" title="back"> <div class="references">
References</div> <div tag="ref-list"> <ul> <div class="title" tagx="title" title="title">
References</div> <li tag="ref"><a name="bb0005" /><span class="label" tagx="label" title="label">1</span><span class="element-citation'"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Rabi</span><span class="given-names" tagx="given-names" title="given-names">F.A.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Al Zoubi</span><span class="given-names" tagx="given-names" title="given-names">M.S.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Kasasbeh</span><span class="given-names" tagx="given-names" title="given-names">G.A.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Salameh</span><span class="given-names" tagx="given-names" title="given-names">D.M.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Al-Nasser</span><span class="given-names" tagx="given-names" title="given-names">A.D.</span></span></span><span class="mixed-article-title" title="mixed-article-title">SARS-CoV-2 and coronavirus disease 2019: what we know so far</span><span class="source" tagx="source" title="source">Pathogens</span><span class="volume" tagx="volume" title="volume">9</span><span class="year" tagx="year" title="year">2020</span><span class="fpage" tagx="fpage" title="fpage">231</span></span></li> <li tag="ref"><a name="bb0010" /><span class="label" tagx="label" title="label">2</span><span class="element-citation'"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Cui</span><span class="given-names" tagx="given-names" title="given-names">J.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Li</span><span class="given-names" tagx="given-names" title="given-names">F.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Shi</span><span class="given-names" tagx="given-names" title="given-names">Z.-L.</span></span></span><span class="mixed-article-title" title="mixed-article-title">Origin and evolution of pathogenic coronaviruses</span><span class="source" tagx="source" title="source">Nat. Rev. Microbiol.</span><span class="volume" tagx="volume" title="volume">17</span><span class="year" tagx="year" title="year">2019</span><span class="fpage" tagx="fpage" title="fpage">181</span><span class="lpage" tagx="lpage" title="lpage">192</span><span class="pub-id"><a href="http://www.ncbi.nlm.nih.gov/pubmed/30531947">30531947</a></span></span></li> <li tag="ref"><a name="bb0015" /><span class="label" tagx="label" title="label">3</span><span class="element-citation'"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Zhou</span><span class="given-names" tagx="given-names" title="given-names">P.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Fan</span><span class="given-names" tagx="given-names" title="given-names">H.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Lan</span><span class="given-names" tagx="given-names" title="given-names">T.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Yang</span><span class="given-names" tagx="given-names" title="given-names">X.-L.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Shi</span><span class="given-names" tagx="given-names" title="given-names">W.-F.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Zhang</span><span class="given-names" tagx="given-names" title="given-names">W.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Zhu</span><span class="given-names" tagx="given-names" title="given-names">Y.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Zhang</span><span class="given-names" tagx="given-names" title="given-names">Y.-W.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Xie</span><span class="given-names" tagx="given-names" title="given-names">Q.-M.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Mani</span><span class="given-names" tagx="given-names" title="given-names">S.</span></span></span><span class="mixed-article-title" title="mixed-article-title">Fatal swine acute diarrhoea syndrome caused by an HKU2-related coronavirus of bat origin</span><span class="source" tagx="source" title="source">Nature</span><span class="volume" tagx="volume" title="volume">556</span><span class="year" tagx="year" title="year">2018</span><span class="fpage" tagx="fpage" title="fpage">255</span><span class="lpage" tagx="lpage" title="lpage">258</span><span class="pub-id"><a href="http://www.ncbi.nlm.nih.gov/pubmed/29618817">29618817</a></span></span></li> <li tag="ref"><a name="bb0020" /><span class="label" tagx="label" title="label">4</span><span class="element-citation'"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Fan</span><span class="given-names" tagx="given-names" title="given-names">Y.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Zhao</span><span class="given-names" tagx="given-names" title="given-names">K.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Shi</span><span class="given-names" tagx="given-names" title="given-names">Z.-L.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Zhou</span><span class="given-names" tagx="given-names" title="given-names">P.</span></span></span><span class="mixed-article-title" title="mixed-article-title">Bat coronaviruses in China</span><span class="source" tagx="source" title="source">Viruses</span><span class="volume" tagx="volume" title="volume">11</span><span class="year" tagx="year" title="year">2019</span><span class="fpage" tagx="fpage" title="fpage">210</span><span class="pub-id"><a href="https://dx.doi.org/10.3390/v11030210">10.3390/v11030210</a></span></span></li> <li tag="ref"><a name="bb0025" /><span class="label" tagx="label" title="label">5</span><span class="element-citation'"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Zhou</span><span class="given-names" tagx="given-names" title="given-names">P.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Yang</span><span class="given-names" tagx="given-names" title="given-names">X.-L.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Wang</span><span class="given-names" tagx="given-names" title="given-names">X.-G.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Hu</span><span class="given-names" tagx="given-names" title="given-names">B.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Zhang</span><span class="given-names" tagx="given-names" title="given-names">L.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Zhang</span><span class="given-names" tagx="given-names" title="given-names">W.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Si</span><span class="given-names" tagx="given-names" title="given-names">H.-R.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Zhu</span><span class="given-names" tagx="given-names" title="given-names">Y.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Li</span><span class="given-names" tagx="given-names" title="given-names">B.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Huang</span><span class="given-names" tagx="given-names" title="given-names">C.-L.</span></span></span><span class="mixed-article-title" title="mixed-article-title">A pneumonia outbreak associated with a new coronavirus of probable bat origin</span><span class="source" tagx="source" title="source">Nature</span><span class="year" tagx="year" title="year">2020</span><span class="fpage" tagx="fpage" title="fpage">1</span><span class="lpage" tagx="lpage" title="lpage">4</span></span></li> <li tag="ref"><a name="bb0030" /><span class="label" tagx="label" title="label">6</span><span class="element-citation'"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Wu</span><span class="given-names" tagx="given-names" title="given-names">F.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Zhao</span><span class="given-names" tagx="given-names" title="given-names">S.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Yu</span><span class="given-names" tagx="given-names" title="given-names">B.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Chen</span><span class="given-names" tagx="given-names" title="given-names">Y.-M.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Wang</span><span class="given-names" tagx="given-names" title="given-names">W.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Song</span><span class="given-names" tagx="given-names" title="given-names">Z.-G.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Hu</span><span class="given-names" tagx="given-names" title="given-names">Y.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Tao</span><span class="given-names" tagx="given-names" title="given-names">Z.-W.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Tian</span><span class="given-names" tagx="given-names" title="given-names">J.-H.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Pei</span><span class="given-names" tagx="given-names" title="given-names">Y.-Y.</span></span></span><span class="mixed-article-title" title="mixed-article-title">A new coronavirus associated with human respiratory disease in China</span><span class="source" tagx="source" title="source">Nature</span><span class="volume" tagx="volume" title="volume">579</span><span class="year" tagx="year" title="year">2020</span><span class="fpage" tagx="fpage" title="fpage">265</span><span class="lpage" tagx="lpage" title="lpage">269</span><span class="pub-id"><a href="http://www.ncbi.nlm.nih.gov/pubmed/32015508">32015508</a></span></span></li> <li tag="ref"><a name="bb0035" /><span class="label" tagx="label" title="label">7</span><span class="element-citation'"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Gorbalenya</span><span class="given-names" tagx="given-names" title="given-names">A.E.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Baker</span><span class="given-names" tagx="given-names" title="given-names">S.C.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Baric</span><span class="given-names" tagx="given-names" title="given-names">R.S.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">de Groot</span><span class="given-names" tagx="given-names" title="given-names">R.J.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Drosten</span><span class="given-names" tagx="given-names" title="given-names">C.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Gulyaeva</span><span class="given-names" tagx="given-names" title="given-names">A.A.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Haagmans</span><span class="given-names" tagx="given-names" title="given-names">B.L.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Lauber</span><span class="given-names" tagx="given-names" title="given-names">C.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Leontovich</span><span class="given-names" tagx="given-names" title="given-names">A.M.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Neuman</span><span class="given-names" tagx="given-names" title="given-names">B.W.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Penzar</span><span class="given-names" tagx="given-names" title="given-names">D.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Perlman</span><span class="given-names" tagx="given-names" title="given-names">S.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Poon</span><span class="given-names" tagx="given-names" title="given-names">L.L.M.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Samborskiy</span><span class="given-names" tagx="given-names" title="given-names">D.V</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Sidorov</span><span class="given-names" tagx="given-names" title="given-names">I.A.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Sola</span><span class="given-names" tagx="given-names" title="given-names">I.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Ziebuhr</span><span class="given-names" tagx="given-names" title="given-names">J.</span></span><span class="collab'">collab: C.S.G. of the I.C. on T. of Viruses</span></span><span class="mixed-article-title" title="mixed-article-title">The species Severe acute respiratory syndrome-related coronavirus: classifying 2019-nCoV and naming it SARS-CoV-2</span><span class="source" tagx="source" title="source">Nat. Microbiol.</span><span class="volume" tagx="volume" title="volume">5</span><span class="year" tagx="year" title="year">2020</span><span class="fpage" tagx="fpage" title="fpage">536</span><span class="lpage" tagx="lpage" title="lpage">544</span><span class="pub-id"><a href="https://dx.doi.org/10.1038/s41564-020-0695-z">10.1038/s41564-020-0695-z</a></span><span class="pub-id"><a href="http://www.ncbi.nlm.nih.gov/pubmed/32123347">32123347</a></span></span></li> <li tag="ref"><a name="bb0040" /><span class="label" tagx="label" title="label">8</span><span class="element-citation'"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Zhang</span><span class="given-names" tagx="given-names" title="given-names">L.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Lin</span><span class="given-names" tagx="given-names" title="given-names">D.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Sun</span><span class="given-names" tagx="given-names" title="given-names">X.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Curth</span><span class="given-names" tagx="given-names" title="given-names">U.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Drosten</span><span class="given-names" tagx="given-names" title="given-names">C.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Sauerhering</span><span class="given-names" tagx="given-names" title="given-names">L.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Becker</span><span class="given-names" tagx="given-names" title="given-names">S.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Rox</span><span class="given-names" tagx="given-names" title="given-names">K.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Hilgenfeld</span><span class="given-names" tagx="given-names" title="given-names">R.</span></span></span><span class="mixed-article-title" title="mixed-article-title">Crystal structure of SARS-CoV-2 main protease provides a basis for design of improved Î±-ketoamide inhibitors</span><span class="source" tagx="source" title="source">Science (80-.)</span><span class="year" tagx="year" title="year">2020</span><span class="pub-id"><a href="https://dx.doi.org/10.1126/science.abb3405">10.1126/science.abb3405</a></span></span></li> <li tag="ref"><a name="bb0045" /><span class="label" tagx="label" title="label">9</span><span class="element-citation'"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Kuba</span><span class="given-names" tagx="given-names" title="given-names">K.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Imai</span><span class="given-names" tagx="given-names" title="given-names">Y.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Rao</span><span class="given-names" tagx="given-names" title="given-names">S.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Gao</span><span class="given-names" tagx="given-names" title="given-names">H.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Guo</span><span class="given-names" tagx="given-names" title="given-names">F.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Guan</span><span class="given-names" tagx="given-names" title="given-names">B.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Huan</span><span class="given-names" tagx="given-names" title="given-names">Y.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Yang</span><span class="given-names" tagx="given-names" title="given-names">P.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Zhang</span><span class="given-names" tagx="given-names" title="given-names">Y.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Deng</span><span class="given-names" tagx="given-names" title="given-names">W.</span></span></span><span class="mixed-article-title" title="mixed-article-title">A crucial role of angiotensin converting enzyme 2 (ACE2) in SARS coronavirus--induced lung injury, Nat</span><span class="source" tagx="source" title="source">Med</span><span class="volume" tagx="volume" title="volume">11</span><span class="year" tagx="year" title="year">2005</span><span class="fpage" tagx="fpage" title="fpage">875</span><span class="lpage" tagx="lpage" title="lpage">879</span></span></li> <li tag="ref"><a name="bb0050" /><span class="label" tagx="label" title="label">10</span><span class="element-citation'"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Anand</span><span class="given-names" tagx="given-names" title="given-names">K.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Ziebuhr</span><span class="given-names" tagx="given-names" title="given-names">J.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Wadhwani</span><span class="given-names" tagx="given-names" title="given-names">P.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Mesters</span><span class="given-names" tagx="given-names" title="given-names">J.R.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Hilgenfeld</span><span class="given-names" tagx="given-names" title="given-names">R.</span></span></span><span class="mixed-article-title" title="mixed-article-title">Coronavirus main proteinase (3CLpro) structure: basis for design of anti-SARS drugs</span><span class="source" tagx="source" title="source">Science (80-. )</span><span class="volume" tagx="volume" title="volume">300</span><span class="year" tagx="year" title="year">2003</span><span class="fpage" tagx="fpage" title="fpage">1763</span><span class="lpage" tagx="lpage" title="lpage">1767</span></span></li> <li tag="ref"><a name="bb0055" /><span class="label" tagx="label" title="label">11</span><span class="element-citation'"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Hilgenfeld</span><span class="given-names" tagx="given-names" title="given-names">R.</span></span></span><span class="mixed-article-title" title="mixed-article-title">From SARS to MERS: crystallographic studies on coronaviral proteases enable antiviral drug design</span><span class="source" tagx="source" title="source">FEBS J.</span><span class="volume" tagx="volume" title="volume">281</span><span class="year" tagx="year" title="year">2014</span><span class="fpage" tagx="fpage" title="fpage">4085</span><span class="lpage" tagx="lpage" title="lpage">4096</span><span class="pub-id"><a href="http://www.ncbi.nlm.nih.gov/pubmed/25039866">25039866</a></span></span></li> <li tag="ref"><a name="bb0060" /><span class="label" tagx="label" title="label">12</span><span class="element-citation'"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Meng</span><span class="given-names" tagx="given-names" title="given-names">X.-Y.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Zhang</span><span class="given-names" tagx="given-names" title="given-names">H.-X.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Mezei</span><span class="given-names" tagx="given-names" title="given-names">M.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Cui</span><span class="given-names" tagx="given-names" title="given-names">M.</span></span></span><span class="mixed-article-title" title="mixed-article-title">Molecular docking: a powerful approach for structure-based drug discovery</span><span class="source" tagx="source" title="source">Curr. Comput. Aided. Drug Des.</span><span class="volume" tagx="volume" title="volume">7</span><span class="year" tagx="year" title="year">2011</span><span class="fpage" tagx="fpage" title="fpage">146</span><span class="lpage" tagx="lpage" title="lpage">157</span><span class="pub-id"><a href="http://www.ncbi.nlm.nih.gov/pubmed/21534921">21534921</a></span></span></li> <li tag="ref"><a name="bb0065" /><span class="label" tagx="label" title="label">13</span><span class="element-citation'"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Sethi</span><span class="given-names" tagx="given-names" title="given-names">A.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Joshi</span><span class="given-names" tagx="given-names" title="given-names">K.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Sasikala</span><span class="given-names" tagx="given-names" title="given-names">K.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Alvala</span><span class="given-names" tagx="given-names" title="given-names">M.</span></span></span><span class="chapter-title" tagx="chapter-title" title="chapter-title">Molecular docking in modern drug discovery: principles and recent applications</span><span class="source" tagx="source" title="source">Drug Discov. Dev. Adv</span><span class="year" tagx="year" title="year">2019</span><span class="publisher-name" tagx="publisher-name" title="publisher-name">IntechOpen</span></span></li> <li tag="ref"><a name="bb0070" /><span class="label" tagx="label" title="label">14</span><span class="element-citation'"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Liu</span><span class="given-names" tagx="given-names" title="given-names">A.-L.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Du</span><span class="given-names" tagx="given-names" title="given-names">G.-H.</span></span></span><span class="chapter-title" tagx="chapter-title" title="chapter-title">Antiviral properties of phytochemicals</span><span class="source" tagx="source" title="source">Diet. Phytochem. Microbes</span><span class="year" tagx="year" title="year">2012</span><span class="publisher-name" tagx="publisher-name" title="publisher-name">Springer</span><span class="fpage" tagx="fpage" title="fpage">93</span><span class="lpage" tagx="lpage" title="lpage">126</span></span></li> <li tag="ref"><a name="bb0075" /><span class="label" tagx="label" title="label">15</span><span class="element-citation'"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Newman</span><span class="given-names" tagx="given-names" title="given-names">D.J.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Cragg</span><span class="given-names" tagx="given-names" title="given-names">G.M.</span></span></span><span class="mixed-article-title" title="mixed-article-title">Natural products as sources of new drugs over the last 25 years</span><span class="source" tagx="source" title="source">J. Nat. Prod.</span><span class="volume" tagx="volume" title="volume">70</span><span class="year" tagx="year" title="year">2007</span><span class="fpage" tagx="fpage" title="fpage">461</span><span class="lpage" tagx="lpage" title="lpage">477</span><span class="pub-id"><a href="http://www.ncbi.nlm.nih.gov/pubmed/17309302">17309302</a></span></span></li> <li tag="ref"><a name="bb0080" /><span class="label" tagx="label" title="label">16</span><span class="element-citation'"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Notka</span><span class="given-names" tagx="given-names" title="given-names">F.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Meier</span><span class="given-names" tagx="given-names" title="given-names">G.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Wagner</span><span class="given-names" tagx="given-names" title="given-names">R.</span></span></span><span class="mixed-article-title" title="mixed-article-title">Concerted inhibitory activities of Phyllanthus amarus on HIV replication in vitro and ex vivo</span><span class="source" tagx="source" title="source">Antivir. Res.</span><span class="volume" tagx="volume" title="volume">64</span><span class="year" tagx="year" title="year">2004</span><span class="fpage" tagx="fpage" title="fpage">93</span><span class="lpage" tagx="lpage" title="lpage">102</span><span class="pub-id"><a href="http://www.ncbi.nlm.nih.gov/pubmed/15498604">15498604</a></span></span></li> <li tag="ref"><a name="bb0085" /><span class="label" tagx="label" title="label">17</span><span class="element-citation'"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Parida</span><span class="given-names" tagx="given-names" title="given-names">M.M.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Upadhyay</span><span class="given-names" tagx="given-names" title="given-names">C.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Pandya</span><span class="given-names" tagx="given-names" title="given-names">G.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Jana</span><span class="given-names" tagx="given-names" title="given-names">A.M.</span></span></span><span class="mixed-article-title" title="mixed-article-title">Inhibitory potential of neem (Azadirachta indica Juss) leaves on dengue virus type-2 replication</span><span class="source" tagx="source" title="source">J. Ethnopharmacol.</span><span class="volume" tagx="volume" title="volume">79</span><span class="year" tagx="year" title="year">2002</span><span class="fpage" tagx="fpage" title="fpage">273</span><span class="lpage" tagx="lpage" title="lpage">278</span><span class="pub-id"><a href="http://www.ncbi.nlm.nih.gov/pubmed/11801392">11801392</a></span></span></li> <li tag="ref"><a name="bb0090" /><span class="label" tagx="label" title="label">18</span><span class="element-citation'"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Serkedjieva</span><span class="given-names" tagx="given-names" title="given-names">J.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Ivancheva</span><span class="given-names" tagx="given-names" title="given-names">S.</span></span></span><span class="mixed-article-title" title="mixed-article-title">Antiherpes virus activity of extracts from the medicinal plant Geranium sanguineum L</span><span class="source" tagx="source" title="source">J. Ethnopharmacol.</span><span class="volume" tagx="volume" title="volume">64</span><span class="year" tagx="year" title="year">1998</span><span class="fpage" tagx="fpage" title="fpage">59</span><span class="lpage" tagx="lpage" title="lpage">68</span></span></li> <li tag="ref"><a name="bb0095" /><span class="label" tagx="label" title="label">19</span><span class="element-citation'"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Rehman</span><span class="given-names" tagx="given-names" title="given-names">S.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Ashfaq</span><span class="given-names" tagx="given-names" title="given-names">U.A.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Riaz</span><span class="given-names" tagx="given-names" title="given-names">S.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Javed</span><span class="given-names" tagx="given-names" title="given-names">T.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Riazuddin</span><span class="given-names" tagx="given-names" title="given-names">S.</span></span></span><span class="mixed-article-title" title="mixed-article-title">Antiviral activity of Acacia nilotica against hepatitis C virus in liver infected cells</span><span class="source" tagx="source" title="source">Virol. J.</span><span class="volume" tagx="volume" title="volume">8</span><span class="year" tagx="year" title="year">2011</span><span class="fpage" tagx="fpage" title="fpage">220</span><span class="pub-id"><a href="http://www.ncbi.nlm.nih.gov/pubmed/21569385">21569385</a></span></span></li> <li tag="ref"><a name="bb0100" /><span class="label" tagx="label" title="label">20</span><span class="element-citation'"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Halgren</span><span class="given-names" tagx="given-names" title="given-names">T.A.</span></span></span><span class="mixed-article-title" title="mixed-article-title">Merck molecular force field. I. Basis, form, scope, parameterization, and performance of MMFF94</span><span class="source" tagx="source" title="source">J. Comput. Chem.</span><span class="volume" tagx="volume" title="volume">17</span><span class="year" tagx="year" title="year">1996</span><span class="fpage" tagx="fpage" title="fpage">490</span><span class="lpage" tagx="lpage" title="lpage">519</span><span class="pub-id"><a href="https://dx.doi.org/10.1002/(SICI)1096-987X(199604)17:5/6&lt;490::AID-JCC1&gt;3.0.CO;2-P">10.1002/(SICI)1096-987X(199604)17:5/6&amp;lt;490::AID-JCC1&amp;gt;3.0.CO;2-P</a></span></span></li> <li tag="ref"><a name="bb0105" /><span class="label" tagx="label" title="label">21</span><span class="element-citation'"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Gurung</span><span class="given-names" tagx="given-names" title="given-names">A.B.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Bhattacharjee</span><span class="given-names" tagx="given-names" title="given-names">A.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Ali</span><span class="given-names" tagx="given-names" title="given-names">M.A.</span></span></span><span class="mixed-article-title" title="mixed-article-title">Exploring the physicochemical profile and the binding patterns of selected novel anticancer Himalayan plant derived active compounds with macromolecular targets</span><span class="source" tagx="source" title="source">Informatics Med. Unlocked.</span><span class="volume" tagx="volume" title="volume">5</span><span class="year" tagx="year" title="year">2016</span><span class="fpage" tagx="fpage" title="fpage">1</span><span class="lpage" tagx="lpage" title="lpage">14</span></span></li> <li tag="ref"><a name="bb0110" /><span class="label" tagx="label" title="label">22</span><span class="element-citation'"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Kim</span><span class="given-names" tagx="given-names" title="given-names">S.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Thiessen</span><span class="given-names" tagx="given-names" title="given-names">P.A.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Bolton</span><span class="given-names" tagx="given-names" title="given-names">E.E.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Chen</span><span class="given-names" tagx="given-names" title="given-names">J.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Fu</span><span class="given-names" tagx="given-names" title="given-names">G.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Gindulyte</span><span class="given-names" tagx="given-names" title="given-names">A.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Han</span><span class="given-names" tagx="given-names" title="given-names">L.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">He</span><span class="given-names" tagx="given-names" title="given-names">J.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">He</span><span class="given-names" tagx="given-names" title="given-names">S.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Shoemaker</span><span class="given-names" tagx="given-names" title="given-names">B.A.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Wang</span><span class="given-names" tagx="given-names" title="given-names">J.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Yu</span><span class="given-names" tagx="given-names" title="given-names">B.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Zhang</span><span class="given-names" tagx="given-names" title="given-names">J.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Bryant</span><span class="given-names" tagx="given-names" title="given-names">S.H.</span></span></span><span class="mixed-article-title" title="mixed-article-title">PubChem substance and compound databases</span><span class="source" tagx="source" title="source">Nucleic Acids Res.</span><span class="volume" tagx="volume" title="volume">44</span><span class="year" tagx="year" title="year">2016</span><span class="fpage" tagx="fpage" title="fpage">D1202</span><span class="lpage" tagx="lpage" title="lpage">D1213</span><span class="pub-id"><a href="https://dx.doi.org/10.1093/nar/gkv951">10.1093/nar/gkv951</a></span><span class="pub-id"><a href="http://www.ncbi.nlm.nih.gov/pubmed/26400175">26400175</a></span></span></li> <li tag="ref"><a name="bb0115" /><span class="label" tagx="label" title="label">23</span><span class="element-citation'"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Lipinski</span><span class="given-names" tagx="given-names" title="given-names">C.A.</span></span></span><span class="mixed-article-title" title="mixed-article-title">Lead- and drug-like compounds: the rule-of-five revolution</span><span class="source" tagx="source" title="source">Drug Discov. Today Technol.</span><span class="volume" tagx="volume" title="volume">1</span><span class="year" tagx="year" title="year">2004</span><span class="fpage" tagx="fpage" title="fpage">337</span><span class="lpage" tagx="lpage" title="lpage">341</span><span class="pub-id"><a href="https://dx.doi.org/10.1016/j.ddtec.2004.11.007">10.1016/j.ddtec.2004.11.007</a></span><span class="pub-id"><a href="http://www.ncbi.nlm.nih.gov/pubmed/24981612">24981612</a></span></span></li> <li tag="ref"><a name="bb0120" /><span class="label" tagx="label" title="label">24</span><span class="element-citation'"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Sander</span><span class="given-names" tagx="given-names" title="given-names">T.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Freyss</span><span class="given-names" tagx="given-names" title="given-names">J.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Korff</span><span class="given-names" tagx="given-names" title="given-names">M. von</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Rufener</span><span class="given-names" tagx="given-names" title="given-names">C.</span></span></span><span class="mixed-article-title" title="mixed-article-title">DataWarrior: an open-source program for chemistry aware data visualization and analysis</span><span class="source" tagx="source" title="source">J. Chem. Inf. Model.</span><span class="volume" tagx="volume" title="volume">55</span><span class="year" tagx="year" title="year">2015</span><span class="fpage" tagx="fpage" title="fpage">460</span><span class="lpage" tagx="lpage" title="lpage">473</span><span class="pub-id"><a href="https://dx.doi.org/10.1021/ci500588j">10.1021/ci500588j</a></span><span class="pub-id"><a href="http://www.ncbi.nlm.nih.gov/pubmed/25558886">25558886</a></span></span></li> <li tag="ref"><a name="bb0125" /><span class="label" tagx="label" title="label">25</span><span class="element-citation'"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Gurung</span><span class="given-names" tagx="given-names" title="given-names">A.B.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Ali</span><span class="given-names" tagx="given-names" title="given-names">M.A.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Bhattacharjee</span><span class="given-names" tagx="given-names" title="given-names">A.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">AbulFarah</span><span class="given-names" tagx="given-names" title="given-names">M.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Al-Hemaid</span><span class="given-names" tagx="given-names" title="given-names">F.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Abou-Tarboush</span><span class="given-names" tagx="given-names" title="given-names">F.M.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Al-Anazi</span><span class="given-names" tagx="given-names" title="given-names">K.M.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Al-Anazi</span><span class="given-names" tagx="given-names" title="given-names">F.S.M.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Lee</span><span class="given-names" tagx="given-names" title="given-names">J.</span></span></span><span class="mixed-article-title" title="mixed-article-title">Molecular docking of the anticancer bioactive compound proceraside with macromolecules involved in the cell cycle and DNA replication</span><span class="source" tagx="source" title="source">Genet. Mol. Res.</span><span class="volume" tagx="volume" title="volume">15</span><span class="year" tagx="year" title="year">2016</span><span class="pub-id"><a href="https://dx.doi.org/10.4238/gmr.15027829">10.4238/gmr.15027829</a></span></span></li> <li tag="ref"><a name="bb0130" /><span class="label" tagx="label" title="label">26</span><span class="element-citation'"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Thompson</span><span class="given-names" tagx="given-names" title="given-names">J.D.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Higgins</span><span class="given-names" tagx="given-names" title="given-names">D.G.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Gibson</span><span class="given-names" tagx="given-names" title="given-names">T.J.</span></span></span><span class="mixed-article-title" title="mixed-article-title">CLUSTAL W: improving the sensitivity of progressive multiple sequence alignment through sequence weighting, position-specific gap penalties and weight matrix choice</span><span class="source" tagx="source" title="source">Nucleic Acids Res.</span><span class="volume" tagx="volume" title="volume">22</span><span class="year" tagx="year" title="year">1994</span><span class="fpage" tagx="fpage" title="fpage">4673</span><span class="lpage" tagx="lpage" title="lpage">4680</span><span class="pub-id"><a href="http://www.ncbi.nlm.nih.gov/pubmed/7984417">7984417</a></span></span></li> <li tag="ref"><a name="bb0135" /><span class="label" tagx="label" title="label">27</span><span class="element-citation'"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Pettersen</span><span class="given-names" tagx="given-names" title="given-names">E.F.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Goddard</span><span class="given-names" tagx="given-names" title="given-names">T.D.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Huang</span><span class="given-names" tagx="given-names" title="given-names">C.C.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Couch</span><span class="given-names" tagx="given-names" title="given-names">G.S.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Greenblatt</span><span class="given-names" tagx="given-names" title="given-names">D.M.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Meng</span><span class="given-names" tagx="given-names" title="given-names">E.C.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Ferrin</span><span class="given-names" tagx="given-names" title="given-names">T.E.</span></span></span><span class="mixed-article-title" title="mixed-article-title">UCSF chimeraâ€"a visualization system for exploratory research and analysis</span><span class="source" tagx="source" title="source">J. Comput. Chem.</span><span class="volume" tagx="volume" title="volume">25</span><span class="year" tagx="year" title="year">2004</span><span class="fpage" tagx="fpage" title="fpage">1605</span><span class="lpage" tagx="lpage" title="lpage">1612</span><span class="pub-id"><a href="https://dx.doi.org/10.1002/jcc.20084">10.1002/jcc.20084</a></span><span class="pub-id"><a href="http://www.ncbi.nlm.nih.gov/pubmed/15264254">15264254</a></span></span></li> <li tag="ref"><a name="bb0140" /><span class="label" tagx="label" title="label">28</span><span class="element-citation'"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Morris</span><span class="given-names" tagx="given-names" title="given-names">G.M.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Huey</span><span class="given-names" tagx="given-names" title="given-names">R.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Lindstrom</span><span class="given-names" tagx="given-names" title="given-names">W.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Sanner</span><span class="given-names" tagx="given-names" title="given-names">M.F.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Belew</span><span class="given-names" tagx="given-names" title="given-names">R.K.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Goodsell</span><span class="given-names" tagx="given-names" title="given-names">D.S.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Olson</span><span class="given-names" tagx="given-names" title="given-names">A.J.</span></span></span><span class="mixed-article-title" title="mixed-article-title">AutoDock4 and AutoDockTools4: automated docking with selective receptor flexibility</span><span class="source" tagx="source" title="source">J. Comput. Chem.</span><span class="volume" tagx="volume" title="volume">30</span><span class="year" tagx="year" title="year">2009</span><span class="fpage" tagx="fpage" title="fpage">2785</span><span class="lpage" tagx="lpage" title="lpage">2791</span><span class="pub-id"><a href="https://dx.doi.org/10.1002/jcc.21256">10.1002/jcc.21256</a></span><span class="pub-id"><a href="http://www.ncbi.nlm.nih.gov/pubmed/19399780">19399780</a></span></span></li> <li tag="ref"><a name="bb0145" /><span class="label" tagx="label" title="label">29</span><span class="element-citation'"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Du</span><span class="given-names" tagx="given-names" title="given-names">X.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Li</span><span class="given-names" tagx="given-names" title="given-names">Y.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Xia</span><span class="given-names" tagx="given-names" title="given-names">Y.-L.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Ai</span><span class="given-names" tagx="given-names" title="given-names">S.-M.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Liang</span><span class="given-names" tagx="given-names" title="given-names">J.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Sang</span><span class="given-names" tagx="given-names" title="given-names">P.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Ji</span><span class="given-names" tagx="given-names" title="given-names">X.-L.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Liu</span><span class="given-names" tagx="given-names" title="given-names">S.-Q.</span></span></span><span class="mixed-article-title" title="mixed-article-title">Insights into protein-ligand interactions: mechanisms, models, and methods</span><span class="source" tagx="source" title="source">Int. J. Mol. Sci.</span><span class="volume" tagx="volume" title="volume">17</span><span class="year" tagx="year" title="year">2016</span><span class="fpage" tagx="fpage" title="fpage">144</span><span class="pub-id"><a href="https://dx.doi.org/10.3390/ijms17020144">10.3390/ijms17020144</a></span></span></li> <li tag="ref"><a name="bb0150" /><span class="label" tagx="label" title="label">30</span><span class="element-citation'"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Adejoro</span><span class="given-names" tagx="given-names" title="given-names">I.A.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Waheed</span><span class="given-names" tagx="given-names" title="given-names">S.O.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Adeboye</span><span class="given-names" tagx="given-names" title="given-names">O.O.</span></span></span><span class="mixed-article-title" title="mixed-article-title">Molecular docking studies of Lonchocarpus cyanescens triterpenoids as inhibitors for malaria</span><span class="source" tagx="source" title="source">J. Phys. Chem. Biophys.</span><span class="volume" tagx="volume" title="volume">6</span><span class="year" tagx="year" title="year">2016</span><span class="fpage" tagx="fpage" title="fpage">398</span><span class="lpage" tagx="lpage" title="lpage">2161</span></span></li> <li tag="ref"><a name="bb0155" /><span class="label" tagx="label" title="label">31</span><span class="element-citation'"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Laskowski</span><span class="given-names" tagx="given-names" title="given-names">R.A.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Swindells</span><span class="given-names" tagx="given-names" title="given-names">M.B.</span></span></span><span class="mixed-article-title" title="mixed-article-title">LigPlot+: multiple ligand-protein interaction diagrams for drug discovery</span><span class="source" tagx="source" title="source">J. Chem. Inf. Model.</span><span class="volume" tagx="volume" title="volume">51</span><span class="year" tagx="year" title="year">2011</span><span class="fpage" tagx="fpage" title="fpage">2778</span><span class="lpage" tagx="lpage" title="lpage">2786</span><span class="pub-id"><a href="https://dx.doi.org/10.1021/ci200227u">10.1021/ci200227u</a></span><span class="pub-id"><a href="http://www.ncbi.nlm.nih.gov/pubmed/21919503">21919503</a></span></span></li> <li tag="ref"><a name="bb0160" /><span class="label" tagx="label" title="label">32</span><span class="element-citation'"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Xue</span><span class="given-names" tagx="given-names" title="given-names">X.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Yu</span><span class="given-names" tagx="given-names" title="given-names">H.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Yang</span><span class="given-names" tagx="given-names" title="given-names">H.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Xue</span><span class="given-names" tagx="given-names" title="given-names">F.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Wu</span><span class="given-names" tagx="given-names" title="given-names">Z.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Shen</span><span class="given-names" tagx="given-names" title="given-names">W.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Li</span><span class="given-names" tagx="given-names" title="given-names">J.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Zhou</span><span class="given-names" tagx="given-names" title="given-names">Z.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Ding</span><span class="given-names" tagx="given-names" title="given-names">Y.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Zhao</span><span class="given-names" tagx="given-names" title="given-names">Q.</span></span></span><span class="mixed-article-title" title="mixed-article-title">Structures of two coronavirus main proteases: implications for substrate binding and antiviral drug design</span><span class="source" tagx="source" title="source">J. Virol.</span><span class="volume" tagx="volume" title="volume">82</span><span class="year" tagx="year" title="year">2008</span><span class="fpage" tagx="fpage" title="fpage">2515</span><span class="lpage" tagx="lpage" title="lpage">2527</span><span class="pub-id"><a href="http://www.ncbi.nlm.nih.gov/pubmed/18094151">18094151</a></span></span></li> <li tag="ref"><a name="bb0165" /><span class="label" tagx="label" title="label">33</span><span class="element-citation'"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Januar</span><span class="given-names" tagx="given-names" title="given-names">H.I.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Dewi</span><span class="given-names" tagx="given-names" title="given-names">A.S.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Marraskuranto</span><span class="given-names" tagx="given-names" title="given-names">E.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Wikanta</span><span class="given-names" tagx="given-names" title="given-names">T.</span></span></span><span class="mixed-article-title" title="mixed-article-title">In silico study of fucoxanthin as a tumor cytotoxic agent</span><span class="source" tagx="source" title="source">J. Pharm. Bioallied Sci.</span><span class="volume" tagx="volume" title="volume">4</span><span class="year" tagx="year" title="year">2012</span><span class="fpage" tagx="fpage" title="fpage">56</span><span class="pub-id"><a href="http://www.ncbi.nlm.nih.gov/pubmed/22368399">22368399</a></span></span></li> <li tag="ref"><a name="bb0170" /><span class="label" tagx="label" title="label">34</span><span class="element-citation'"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Jiang</span><span class="given-names" tagx="given-names" title="given-names">R.-W.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Ma</span><span class="given-names" tagx="given-names" title="given-names">S.-C.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">He</span><span class="given-names" tagx="given-names" title="given-names">Z.-D.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Huang</span><span class="given-names" tagx="given-names" title="given-names">X.-S.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">But</span><span class="given-names" tagx="given-names" title="given-names">P.P.-H.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Wang</span><span class="given-names" tagx="given-names" title="given-names">H.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Chan</span><span class="given-names" tagx="given-names" title="given-names">S.-P.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Ooi</span><span class="given-names" tagx="given-names" title="given-names">V.E.-C.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Xu</span><span class="given-names" tagx="given-names" title="given-names">H.-X.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Mak</span><span class="given-names" tagx="given-names" title="given-names">T.C.W.</span></span></span><span class="mixed-article-title" title="mixed-article-title">Molecular structures and antiviral activities of naturally occurring and modified cassane furanoditerpenoids and friedelane triterpenoids from Caesalpinia minax</span><span class="source" tagx="source" title="source">Bioorg. Med. Chem.</span><span class="volume" tagx="volume" title="volume">10</span><span class="year" tagx="year" title="year">2002</span><span class="fpage" tagx="fpage" title="fpage">2161</span><span class="lpage" tagx="lpage" title="lpage">2170</span><span class="pub-id"><a href="http://www.ncbi.nlm.nih.gov/pubmed/11983512">11983512</a></span></span></li> <li tag="ref"><a name="bb0175" /><span class="label" tagx="label" title="label">35</span><span class="element-citation'"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Orhan</span><span class="given-names" tagx="given-names" title="given-names">D.D.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Ã–zÃ§elik</span><span class="given-names" tagx="given-names" title="given-names">B.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Ã–zgen</span><span class="given-names" tagx="given-names" title="given-names">S.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Ergun</span><span class="given-names" tagx="given-names" title="given-names">F.</span></span></span><span class="mixed-article-title" title="mixed-article-title">Antibacterial, antifungal, and antiviral activities of some flavonoids</span><span class="source" tagx="source" title="source">Microbiol. Res.</span><span class="volume" tagx="volume" title="volume">165</span><span class="year" tagx="year" title="year">2010</span><span class="fpage" tagx="fpage" title="fpage">496</span><span class="lpage" tagx="lpage" title="lpage">504</span><span class="pub-id"><a href="http://www.ncbi.nlm.nih.gov/pubmed/19840899">19840899</a></span></span></li> </ul> </div> <div class="supplementary-material" title="supplementary-material"><span class="label" tagx="label" title="label">Appendix A</span><div class="title" tagx="title" title="title">
Supplementary data</div> <p id="p0105"> </p><div class="local-data" title="local-data">  <p>Supplementary tables</p>  <div class="media" title="media"><a href="mmc1.docx">LINK</a><div tag="alt-text">
Image 12</div> </div> </div> <p /> </div> <div class="ack" title="ack"> <div class="title" tagx="title" title="title">
Acknowledgement</div> <p>The author ABG would like to thank the Department of Basic Sciences and Social Sciences for providing the necessary facilities for the research work. The authors would like to extend their sincere appreciation to the Deanship of Scientific Research at </p><div class="funding-source" title="funding-source"> <div class="institution-wrap" title="institution-wrap"><span class="institution-id" title="institution-id">10.13039/501100002383</span><span class="institution" title="institution">King Saud University</span></div> </div> for its funding of the research through the research group project #RG-1438-015.<p /> </div> <div class="fn-group" title="fn-group"> <div class="fn-type-supplementary-material" title="supplementary-material"><span class="label" tagx="label" title="label">Appendix A</span><p id="p0110">Supplementary data to this article can be found online at <a href="https://doi.org/10.1016/j.lfs.2020.117831">https://doi.org/10.1016/j.lfs.2020.117831</a>.</p> </div> </div> </div>  </body></html>